from django.test import TestCase
from collections import OrderedDict
from topics.models import *
from topics.activity_helpers import activity_articles_to_api_results, activities_by_source
from topics.family_tree_helpers import get_parent_orgs, get_child_orgs
import os
from neomodel import db
from datetime import date, datetime
import time
from django.contrib.auth import get_user_model
from topics.serializers import *
from topics.activity_helpers import get_activities_by_country_and_date_range
from integration.rdf_post_processor import RDFPostProcessor, add_dynamic_classes_for_multiple_labels
from integration.tests import make_node, clean_db
import json
import re
from topics.serializers import only_valid_relationships, FamilyTreeSerializer
from topics.industry_geo.orgs_by_industry_geo import build_region_hierarchy, prepare_headers
from topics.industry_geo.hierarchy_utils import filtered_hierarchy, hierarchy_widths
from topics.cache_helpers import refresh_geo_data
from topics.industry_geo import geo_codes_for_region, geo_parent_children
from topics.industry_geo.orgs_by_industry_geo import org_uris_by_industry_id_and_or_geo_code
from topics.industry_geo.org_source_attribution import get_source_orgs_articles_for, get_source_orgs_for_ind_cluster_or_geo_code
import pickle
from topics.organization_search_helpers import search_organizations_by_name
from syracuse.cache_util import nuke_cache, get_active_version, count_keys, get_inactive_version
from syracuse.date_util import min_and_max_date
import copy
from rest_framework import status
from topics.industry_geo.industry_geo_cypher import INDUSTRY_CLUSTER_MIN_WEIGHT_PROPORTION, GEO_LOCATION_MIN_WEIGHT_PROPORTION
from unittest.mock import patch, MagicMock

'''
    Care these tests will delete neodb data
'''
env_var="DELETE_NEO"
if os.environ.get(env_var) != "Y":
    print(f"Set env var {env_var}=Y to confirm you want to drop Neo4j database")
    exit(0)

class TestRegionHierarchy(TestCase):

    @classmethod
    def setUpTestData(cls):
        nuke_cache()

    def setUp(self):
        self.countries = ["GB","CN","CA","US","ZA","AE","SG","NA","SZ"]
        self.admin1s = {"US":["IL","OK","IA","NY"],"CA":["12","13"],"CN":["11","04"]}

    def test_builds_region_hierarchy(self):

        country_hierarchy, country_widths, admin1_hierarchy, admin1_widths = build_region_hierarchy(self.countries, self.admin1s)

        assert country_hierarchy == {'Asia': {'Western Asia': ['AE'], 
                                              'South-eastern Asia': ['SG'],
                                              'Eastern Asia': ['CN']}, 
                                     'Europe': {'Northern Europe': ['GB']}, 
                                     'Africa': {'Sub-Saharan Africa': {'Southern Africa': ['NA', 'SZ', 'ZA']}}, 
                                     'Americas': {'Northern America': ['CA', 'US']}}

        assert country_widths == {'Asia#Western Asia': 1, 'Asia#South-eastern Asia': 1, 'Asia#Eastern Asia': 1, 
                                  'Europe#Northern Europe': 1, 'Africa#Sub-Saharan Africa#Southern Africa': 3, 
                                  'Americas#Northern America': 2, 'Americas': 2, 'Africa#Sub-Saharan Africa': 3, 
                                  'Africa': 3, 'Europe': 1, 'Asia': 3}

        assert admin1_hierarchy == {'US': {'Northeast': {'Mid Atlantic': ['NY']}, 
                                           'Midwest': {'East North Central': ['IL'], 
                                                       'West North Central': ['IA']}, 
                                            'South': {'West South Central': ['OK']}}, 
                                    'CA': ['12', '13'], 'CN': ['04', '11']}

        assert admin1_widths == {'US': {'US#Northeast#Mid Atlantic': 1, 'US#Midwest#East North Central': 1, 
                                        'US#Midwest#West North Central': 1, 'US#South#West South Central': 1, 
                                        'US#South': 1, 'US': 4, 'US#Midwest': 2, 'US#Northeast': 1}, 
                                        'CA': {'CA': 2}, 'CN': {'CN': 2}}
            
        headers = prepare_headers(country_hierarchy, country_widths, admin1_hierarchy, admin1_widths, self.countries, self.admin1s)
        assert headers[0] == OrderedDict([('Africa', {'colspan': 3, 'classes': 'col-NA col-SZ col-ZA'}), 
                                          ('Americas', {'colspan': 8, 'classes': 'col-CA col-CA-12 col-CA-13 col-US col-US-IA col-US-IL col-US-NY col-US-OK'}), 
                                          ('Asia', {'colspan': 5, 'classes': 'col-AE col-CN col-CN-04 col-CN-11 col-SG'}), 
                                          ('Europe', {'colspan': 1, 'classes': 'col-GB'})])
        assert headers[1] == OrderedDict([('Sub-Saharan Africa', {'colspan': 3, 'classes': 'col-NA col-SZ col-ZA'}), 
                                          ('Northern America', {'colspan': 8, 'classes': 'col-CA col-CA-12 col-CA-13 col-US col-US-IA col-US-IL col-US-NY col-US-OK'}), 
                                          ('Eastern Asia', {'colspan': 3, 'classes': 'col-CN col-CN-04 col-CN-11'}), 
                                          ('South-eastern Asia', {'colspan': 1, 'classes': 'col-SG'}), ('Western Asia', {'colspan': 1, 'classes': 'col-AE'}), 
                                          ('Northern Europe', {'colspan': 1, 'classes': 'col-GB'})])  
        assert headers[2] == OrderedDict([('Southern Africa', {'colspan': 3, 'classes': 'col-NA col-SZ col-ZA'}), 
                                          ('REPEATED Northern America', {'colspan': 8, 'classes': 'col-CA col-CA-12 col-CA-13 col-US col-US-IA col-US-IL col-US-NY col-US-OK'}), 
                                          ('REPEATED Eastern Asia', {'colspan': 3, 'classes': 'col-CN col-CN-04 col-CN-11'}), 
                                          ('REPEATED South-eastern Asia', {'colspan': 1, 'classes': 'col-SG'}), 
                                          ('REPEATED Western Asia', {'colspan': 1, 'classes': 'col-AE'}), 
                                          ('REPEATED Northern Europe', {'colspan': 1, 'classes': 'col-GB'})])
        assert headers[3] == OrderedDict([('NA', {'colspan': 1, 'classes': 'col-NA'}), ('SZ', {'colspan': 1, 'classes': 'col-SZ'}), ('ZA', {'colspan': 1, 'classes': 'col-ZA'}), 
                                          ('CA', {'colspan': 3, 'classes': 'col-CA col-CA-12 col-CA-13'}), ('US', {'colspan': 5, 'classes': 'col-US col-US-IA col-US-IL col-US-NY col-US-OK'}), 
                                          ('CN', {'colspan': 3, 'classes': 'col-CN col-CN-04 col-CN-11'}), ('SG', {'colspan': 1, 'classes': 'col-SG'}), 
                                          ('AE', {'colspan': 1, 'classes': 'col-AE'}), ('GB', {'colspan': 1, 'classes': 'col-GB'})])
        assert headers[4] == OrderedDict([('REPEATED NA', {'colspan': 1, 'classes': 'col-NA'}), ('REPEATED SZ', {'colspan': 1, 'classes': 'col-SZ'}), 
                                          ('REPEATED ZA', {'colspan': 1, 'classes': 'col-ZA'}), ('CA (all)', {'colspan': 1, 'classes': 'col-CA'}), 
                                          ('CA-12', {'colspan': 1, 'classes': 'col-CA-12'}), ('CA-13', {'colspan': 1, 'classes': 'col-CA-13'}), 
                                          ('US (all)', {'colspan': 1, 'classes': 'col-US'}), ('Midwest', {'colspan': 2, 'classes': 'col-US-IA col-US-IL'}), 
                                          ('Northeast', {'colspan': 1, 'classes': 'col-US-NY'}), ('South', {'colspan': 1, 'classes': 'col-US-OK'}), 
                                          ('CN (all)', {'colspan': 1, 'classes': 'col-CN'}), ('CN-04', {'colspan': 1, 'classes': 'col-CN-04'}), 
                                          ('CN-11', {'colspan': 1, 'classes': 'col-CN-11'}), ('REPEATED SG', {'colspan': 1, 'classes': 'col-SG'}), 
                                          ('REPEATED AE', {'colspan': 1, 'classes': 'col-AE'}), ('REPEATED GB', {'colspan': 1, 'classes': 'col-GB'})])
        assert headers[5] == OrderedDict([('REPEATED NA', {'colspan': 1, 'classes': 'col-NA'}), ('REPEATED SZ', {'colspan': 1, 'classes': 'col-SZ'}), 
                                          ('REPEATED ZA', {'colspan': 1, 'classes': 'col-ZA'}), ('REPEATED CA (all)', {'colspan': 1, 'classes': 'col-CA'}), 
                                          ('REPEATED CA-12', {'colspan': 1, 'classes': 'col-CA-12'}), ('REPEATED CA-13', {'colspan': 1, 'classes': 'col-CA-13'}), 
                                          ('REPEATED US (all)', {'colspan': 1, 'classes': 'col-US'}), ('East North Central', {'colspan': 1, 'classes': 'col-US-IL'}), 
                                          ('West North Central', {'colspan': 1, 'classes': 'col-US-IA'}), ('Mid Atlantic', {'colspan': 1, 'classes': 'col-US-NY'}), 
                                          ('West South Central', {'colspan': 1, 'classes': 'col-US-OK'}), ('REPEATED CN (all)', {'colspan': 1, 'classes': 'col-CN'}), 
                                          ('REPEATED CN-04', {'colspan': 1, 'classes': 'col-CN-04'}), ('REPEATED CN-11', {'colspan': 1, 'classes': 'col-CN-11'}), 
                                          ('REPEATED SG', {'colspan': 1, 'classes': 'col-SG'}), ('REPEATED AE', {'colspan': 1, 'classes': 'col-AE'}), 
                                          ('REPEATED GB', {'colspan': 1, 'classes': 'col-GB'})])
        assert headers[6] == OrderedDict([('REPEATED NA', {'colspan': 1, 'classes': 'col-NA header_final'}), ('REPEATED SZ', {'colspan': 1, 'classes': 'col-SZ header_final'}), 
                                          ('REPEATED ZA', {'colspan': 1, 'classes': 'col-ZA header_final'}), ('REPEATED CA (all)', {'colspan': 1, 'classes': 'col-CA header_final'}), 
                                          ('REPEATED CA-12', {'colspan': 1, 'classes': 'col-CA-12 header_final'}), ('REPEATED CA-13', {'colspan': 1, 'classes': 'col-CA-13 header_final'}), 
                                          ('REPEATED US (all)', {'colspan': 1, 'classes': 'col-US header_final'}), ('US-IL', {'colspan': 1, 'classes': 'col-US-IL header_final'}), 
                                          ('US-IA', {'colspan': 1, 'classes': 'col-US-IA header_final'}), ('US-NY', {'colspan': 1, 'classes': 'col-US-NY header_final'}), 
                                          ('US-OK', {'colspan': 1, 'classes': 'col-US-OK header_final'}), ('REPEATED CN (all)', {'colspan': 1, 'classes': 'col-CN header_final'}), 
                                          ('REPEATED CN-04', {'colspan': 1, 'classes': 'col-CN-04 header_final'}), ('REPEATED CN-11', {'colspan': 1, 'classes': 'col-CN-11 header_final'}), 
                                          ('REPEATED SG', {'colspan': 1, 'classes': 'col-SG header_final'}), ('REPEATED AE', {'colspan': 1, 'classes': 'col-AE header_final'}), 
                                          ('REPEATED GB', {'colspan': 1, 'classes': 'col-GB header_final'})])

        
    def test_filters_tree(self):
        data = {
            "k1": {
                "k11": {
                    "k111": ["v3", "v2","v1"],
                    "k112": ["v4", "v5"]
                },
                "k12": ["v9", "v8"]
            }
        }
        filtered = filtered_hierarchy(data,["v8","v9","v1","v3","v5"])
        assert filtered ==  {'k1': {'k11': {
                                        'k111': ['v1', 'v3'], 
                                        'k112': ['v5']}, 
                                    'k12': ['v8', 'v9']}}

    def test_calculates_width(self):
        data = {
            "k1": {
                "k11": {
                    "k111": ["v3", "v2","v1"],
                    "k112": ["v4", "v5"]
                },
                "k12": ["v9", "v8"]
            }
        }  
        widths = hierarchy_widths(data)
        assert widths == {'k1':7, 'k1#k12':2, 'k1#k11':5, 'k1#k11#k111': 3, 'k1#k11#k112':2}

    def test_parent_children_for_us_state(self):
        assert geo_parent_children()['US-CA'] == {'parent': 'Pacific', 'id': 'US-CA', 'children': set()}

    def test_parent_children_for_european_country(self):
        assert geo_parent_children()['NL'] == {'parent': 'Western Europe', 'id': 'NL', 'children': set()}

    def test_parent_children_for_us_region(self):
        res = geo_parent_children()['South']
        assert res == {'parent': 'US', 
                        'id': 'South',
                        'children': {'West South Central', 
                                        'East South Central', 'South Atlantic'}}, f"Got {res}"
        
    def test_parent_children_for_un_region(self):
        assert geo_parent_children()["Latin America and the Caribbean"] == {'parent': 'Americas',
                                                                          'id': 'Latin America and the Caribbean', 
                                                                          'children': {'Central America', 
                                                                                       'South America', 'Caribbean'}}


    def test_gets_country_codes_for_lower_region(self):
        af = geo_codes_for_region("Africa")
        ssa = geo_codes_for_region("Sub-Saharan Africa")
        ma = geo_codes_for_region("Middle Africa")
        assert ma == set(['AO', 'CD', 'CF', 'CG', 'CM', 'GA', 'GQ', 'ST', 'TD'])
        assert len(ssa) > len(ma)
        assert len(af) > len(ssa)
        assert ma.issubset(ssa)
        assert ssa.issubset(af)

    def test_finds_midwest_states(self):
        mw = geo_codes_for_region("Midwest")
        assert mw == set(['US-IA', 'US-IL', 'US-IN', 'US-KS', 'US-MI', 'US-MN', 'US-MO', 
                          'US-ND', 'US-NE', 'US-OH', 'US-SD', 'US-WI'])
        


class TestFamilyTree(TestCase):

    @classmethod
    def setUpTestData(cls):
        clean_db()
        org_nodes = [make_node(x,y) for x,y in zip(range(100,200),"abcdefghijklmnz")]
        org_nodes = org_nodes + [make_node(x,y) for x,y in zip(range(200,210),["p1","p2","s1","s2","c1","c2","p3"])]
        org_nodes = sorted(org_nodes, reverse=True)
        act_nodes = [make_node(x,y,"CorporateFinanceActivity") for x,y in zip(range(100,200),"opqrstuvw")]
        act_nodes = act_nodes + [make_node(x,y,"CorporateFinanceActivity") for x,y in zip(range(200,210),["a1","a2","a3","a4"])]
        node_list = ", ".join(org_nodes + act_nodes)
        query = f"""CREATE {node_list},
            (a)-[:buyer]->(q)-[:target]->(b),
            (a)-[:investor]->(r)-[:target]->(c),
            (b)-[:buyer]->(s)-[:target]->(d),

            (e)-[:buyer]->(o)-[:target]->(f),
            (g)-[:investor]->(p)-[:target]->(h),

            (i)-[:buyer]->(w)-[:target]->(j),
            (i)-[:investor]->(t)-[:target]->(k),
            (j)-[:buyer]->(u)-[:target]->(l),

            (m)-[:buyer]->(v)-[:target]->(n),

            (p1)-[:buyer]->(a1)-[:target]->(s1),
            (s2)-[:buyer]->(a2)-[:target]->(c1),
            (p2)-[:buyer]->(a3)-[:target]->(c2),
            (p3)-[:buyer]->(a4)-[:target]->(s1)

            SET a.internalCleanName = ['foo']
            SET e.internalCleanName = ['foo']
            SET b.internalCleanName = ['bar']
            SET g.internalCleanName = ['bar']
            SET z.internalCleanShortName = ['baz']
            SET d.internalCleanShortName = ['baz']
            SET l.internalCleanName = ['qux']
            SET n.internalCleanName = ['qux']
            SET s1.internalCleanName = ['qoz']
            SET s2.internalCleanName = ['qoz']
            SET p1.internalCleanName = ['huy']
            SET p2.internalCleanName = ['huy']
        """
        db.cypher_query(query)
        nuke_cache()

    def setUp(self):
        ts = time.time()
        self.user = get_user_model().objects.create(username=f"test-{ts}")

    def test_gets_parent_orgs_without_same_as_name_only(self):
        uri = "https://1145.am/db/111/l"
        parents = get_parent_orgs(uri,combine_same_as_name_only=False)
        assert len(parents) == 1
        uris = [x.uri for x,_,_,_,_,_ in parents]
        assert set(uris) == set(["https://1145.am/db/109/j"])

    def test_gets_parent_orgs_with_same_as_name_only(self):
        uri = "https://1145.am/db/111/l"
        parents = get_parent_orgs(uri,combine_same_as_name_only=True)
        assert len(parents) == 2
        uris = [x.uri for x,_,_,_,_,_ in parents]
        assert set(uris) == set(["https://1145.am/db/109/j", "https://1145.am/db/112/m"])

    def test_gets_child_orgs_without_same_as_name_only(self):
        uri = "https://1145.am/db/101/b"
        children = get_child_orgs(uri,combine_same_as_name_only=False)
        assert len(children) == 1
        child_uris = [x.uri for (_,x,_,_,_,_) in children]
        assert set(child_uris) == set(["https://1145.am/db/103/d"])

    def test_gets_child_orgs_with_same_as_name_only(self):
        uri = "https://1145.am/db/101/b"
        children = get_child_orgs(uri,combine_same_as_name_only=True)
        assert len(children) == 2
        child_uris = [x.uri for (_,x,_,_,_,_) in children]
        assert set(child_uris) == set(["https://1145.am/db/103/d","https://1145.am/db/107/h"])

    def test_gets_family_tree_without_same_as_name_only(self):
        uri = "https://1145.am/db/101/b"
        o = Organization.self_or_ultimate_target_node(uri)
        nodes_edges = FamilyTreeSerializer(o,context={"combine_same_as_name_only":False,
                                                    "relationship_str":"buyer,vendor,investor"})
        d = nodes_edges.data
        assert len(d['nodes']) == 4
        assert len(d['edges']) == 3
        edge_details = json.loads(d['edge_details'])
        assert len(edge_details) == len(d['edges'])
        node_details = json.loads(d['node_details'])
        assert len(node_details) == len(d['nodes'])

    def test_gets_family_tree_with_same_as_name_only(self):
        uri = "https://1145.am/db/101/b"
        o = Organization.self_or_ultimate_target_node(uri)
        nodes_edges = FamilyTreeSerializer(o,context={"combine_same_as_name_only":True,
                                                       "relationship_str":"buyer,vendor,investor"})
        d = nodes_edges.data
        assert len(d['nodes']) == 6
        assert len(d['edges']) == 5
        edge_details = json.loads(d['edge_details'])
        assert len(edge_details) == len(d['edges'])
        node_details = json.loads(d['node_details'])
        assert len(node_details) == len(d['nodes'])

    def test_gets_children_where_there_is_no_parent(self):
        uri = "https://1145.am/db/100/a"
        o = Organization.self_or_ultimate_target_node(uri)
        nodes_edges = FamilyTreeSerializer(o,context={"combine_same_as_name_only":True,
                                                         "relationship_str":"buyer,vendor,investor"})
        d = nodes_edges.data
        names = [x['label'] for x in d['nodes']]
        assert set(names) == set(["Name A","Name B","Name C","Name F"])

    def test_shows_nodes_in_name_order(self):
        client = self.client
        path = "/organization/family-tree/uri/1145.am/db/101/b?rels=buyer,vendor,investor&min_date=-1&combine_same_as_name_only=1"
        response = client.get(path)
        assert response.status_code == status.HTTP_401_UNAUTHORIZED
        client.force_login(self.user)
        response = client.get(path)
        assert response.status_code == status.HTTP_200_OK
        content = str(response.content)
        res = re.search(r"var edges = new vis.DataSet\( (.+?) \);",content)
        as_dict = json.loads(res.groups(0)[0].replace("\\'","\""))
        target_ids = [x['to'] for x in as_dict]
        expected_ids = ['https://1145.am/db/101/b', 'https://1145.am/db/102/c', 
                          'https://1145.am/db/105/f', 'https://1145.am/db/103/d', 
                          'https://1145.am/db/107/h']
        assert expected_ids == target_ids, f"Got {target_ids} expected {expected_ids}"

    def test_links_parent_and_child_if_only_linked_via_same_as_name_only(self):
        client = self.client
        path = "/organization/family-tree/uri/1145.am/db/202/s1?rels=buyer,vendor&min_date=-1&combine_same_as_name_only=1"
        client.force_login(self.user)
        response = client.get(path)
        content = str(response.content)
        assert "https://1145.am/db/200/p1-buyer-https://1145.am/db/202/s1" in content # link from p1 to s1
        assert "https://1145.am/db/202/s1-buyer-https://1145.am/db/204/c1" in content # link from s1 to c1 (but it was s2 who bought c1)

    def test_switches_sibling_if_parent_has_different_same_as_child(self):
        '''
        Looking for s2, which is sameAsNameOnly with s1, so there shouldn't be any reference to s1 here
        '''
        client = self.client
        client.force_login(self.user)
        response = client.get("/organization/family-tree/uri/1145.am/db/203/s2?min_date=-1&combine_same_as_name_only=1")
        content = str(response.content)
        assert "https://1145.am/db/200/p1-buyer-https://1145.am/db/202/s1" not in content # link from p1 to s1
        assert "https://1145.am/db/200/p1-buyer-https://1145.am/db/203/s2" in content # link from s1 to c1 (but it was s2 who bought c1)

    def test_switches_sibling_if_different_parent_has_same_as_name_only_child(self):
        client = self.client
        client.force_login(self.user)
        response = client.get("/organization/family-tree/uri/1145.am/db/203/s2?min_date=-1&combine_same_as_name_only=1")
        content = str(response.content)
        assert "https://1145.am/db/200/p1-buyer-https://1145.am/db/202/s1" not in content # link from p1 to s1
        assert "https://1145.am/db/200/p1-buyer-https://1145.am/db/203/s2" in content # link from s1 to c1 (but it was s2 who bought c1)

    def test_updates_sibling_target_if_central_org_is_linked_by_same_only(self):
        client = self.client
        client.force_login(self.user)
        response = client.get("/organization/family-tree/uri/1145.am/db/202/s1?rels=buyer,vendor&min_date=-1&combine_same_as_name_only=1")
        content = str(response.content)
        # p3 bought s2, but I'm looking at s1 which has sameAsNameOnly with s2, so should only be seeing s1
        assert 'https://1145.am/db/206/p3-buyer-https://1145.am/db/203/s2' not in content
        assert 'https://1145.am/db/206/p3-buyer-https://1145.am/db/202/s1' in content 

    def test_links_multiple_parents_to_same_child(self):
        client = self.client
        client.force_login(self.user)
        response = client.get("/organization/family-tree/uri/1145.am/db/202/s1")
        content = str(response.content)
        assert 'https://1145.am/db/206/p3-buyer-https://1145.am/db/202/s1' in content, f"Got {len(content)} content"


class TestDynamicClasses(TestCase):

    def test_can_pickle_dynamic_class(self):
        # Needed for caching in redis
        ts = time.time()
        uri = f"https://example.org/foo/bar/{ts}"
        query = f"CREATE (n: Resource&Person&Organization {{uri:'{uri}'}})"
        db.cypher_query(query)
        add_dynamic_classes_for_multiple_labels(ignore_cache=True)
        obj = Resource.nodes.get_or_none(uri=uri)
        res = pickle.dumps(obj)
        unpickled = pickle.loads(res)
        assert obj == unpickled

class TestSerializers(TestCase):

    def test_cleans_relationship_string1(self):
        val = only_valid_relationships("<foobar>vendor</foobar>")
        assert val == "buyer|vendor"

    def test_cleans_relationship_string2(self):
        val = only_valid_relationships("investor|buyer|vendor")
        assert val == "investor|buyer|vendor"


class TestFindResultsWithNodeDegreeCount(TestCase):

    @classmethod
    def setUpTestData(cls):
        clean_db()
        one_year_ago = datetime.now() - timedelta(365)
        five_years_ago = datetime.now() - timedelta(365 * 5)
        node_data = [
            {"doc_id":100,"identifier":"foo_newone","datestamp": one_year_ago},
            {"doc_id":101,"identifier":"foo_oldone","datestamp": five_years_ago},
            {"doc_id":102,"identifier":"bar_newone","datestamp": one_year_ago},
            {"doc_id":103,"identifier":"bar_oldone","datestamp": five_years_ago},
            {"doc_id":200,"identifier":"same_as_one","datestamp": one_year_ago},
            {"doc_id":201,"identifier":"same_as_two","datestamp": one_year_ago},
            {"doc_id":202,"identifier":"same_as_three","datestamp": five_years_ago},
            {"doc_id":203,"identifier":"same_as_four","datestamp": one_year_ago},
            {"doc_id":204,"identifier":"same_as_five","datestamp": five_years_ago},
            {"doc_id":300,"identifier":"same_as_b_one","datestamp": one_year_ago},
            {"doc_id":301,"identifier":"same_as_b_two","datestamp": five_years_ago},
            {"doc_id":302,"identifier":"same_as_b_three","datestamp": one_year_ago},
        ]

        nodes = [make_node(**data) for data in node_data]
        node_list = ", ".join(nodes)
        query = f"""
            CREATE {node_list},
            (ind1: Resource:IndustryCluster {{uri:"https://1145.am/ind1", topicId: 23, representativeDoc:['paper printing','cardboard packaging']}}),
            (ind2: Resource:IndustryCluster {{uri:"https://1145.am/ind2", topicId: 24, representativeDoc:['computers','server hardware']}}),
            (loc1: Resource:GeoNamesLocation {{uri:"https://1145.am/loc1", geoNamesId: 4509884}}), // In US-Ohio
            (loc2: Resource:GeoNamesLocation {{uri:"https://1145.am/loc2", geoNamesId: 4791259}}), // In US-Virginia 
            (loc3: Resource:GeoNamesLocation {{uri:"https://1145.am/loc3", geoNamesId: 4776222}}), // In US-Virginia 

            (foo_newone)-[:industryClusterPrimary {{weight:2}}]->(ind1),
            (foo_oldone)-[:industryClusterPrimary {{weight:2}}]->(ind1),
            (foo_newone)-[:basedInHighGeoNamesLocation {{weight:2}}]->(loc1),
            (bar_newone)-[:basedInHighGeoNamesLocation {{weight:2}}]->(loc1),
            (bar_oldone)-[:basedInHighGeoNamesLocation {{weight:2}}]->(loc1),
            (bar_newone)-[:basedInHighGeoNamesLocation {{weight:1}}]->(loc3),
            
            (loc1)-[:geoNamesURL]->(:Resource {{uri:"https://sws.geonames.org/4509884",sourceOrganization:"source_org_foo"}}),
            (loc2)-[:geoNamesURL]->(:Resource {{uri:"https://sws.geonames.org/4791259",sourceOrganization:"source_org_foo"}}),
            (loc3)-[:geonamesURL]->(:Resource {{uri:"https://sws.geonames.org/4776222",sourceOrganization:"source_org_foo"}})

            SET same_as_one.internalCleanName = ['same_as_one']
            SET same_as_two.internalCleanName = ['same_as_one']
            SET same_as_three.internalCleanName = ['same_as_one']
            SET same_as_four.internalCleanName = ['same_as_one']
            SET same_as_five.internalCleanName = ['same_as_one']

            SET same_as_b_one.internalCleanName = ['same_as_b']
            SET same_as_b_two.internalCleanName = ['same_as_b']
            SET same_as_b_three.internalCleanName = ['same_as_b']

            SET foo_oldone.internalCleanName = ['foo']
            SET foo_newone.internalCleanName = ['foo']
        """            
        db.cypher_query(query)
        RDFPostProcessor().run_all_in_order()
        refresh_geo_data(fill_blanks=True)

    def test_search_by_name_check_counts_without_same_as_name_only(self):
        sorted_res = search_organizations_by_name("foo",True)
        assert sorted_res[0][0].uri == 'https://1145.am/db/100/foo_newone'
        assert sorted_res[0][1] == 3


    def test_search_by_name_check_counts_with_same_as_name_only(self):
        sorted_res = search_organizations_by_name("foo",False)
        assert sorted_res[0][0].uri == 'https://1145.am/db/100/foo_newone'
        assert sorted_res[0][1] == 3
        assert sorted_res[1][0].uri == 'https://1145.am/db/101/foo_oldone'
        assert sorted_res[1][1] == 2


    def test_search_by_geo_counts(self):
        res = org_uris_by_industry_id_and_or_geo_code(None, 'US-OH')
        expected = [('https://1145.am/db/100/foo_newone', 3), 
                       ('https://1145.am/db/102/bar_newone', 3), 
                       ('https://1145.am/db/103/bar_oldone', 2)]
        assert res == expected, f"Got {res}, expected {expected}"

    def test_ignores_weight_1(self):
        res = org_uris_by_industry_id_and_or_geo_code(None, 'US-VA')
        assert res == [] # Only one org is linked to a US-VA location and that is with weight = 1

    def test_search_by_industry_counts_same_as_name_only_false(self):
        res = org_uris_by_industry_id_and_or_geo_code(23, None, combine_same_as_name_only=False)
        assert res == [('https://1145.am/db/100/foo_newone', 3, 100, [[None, None, None], [None, None, None]]), 
                       ('https://1145.am/db/101/foo_oldone', 2, 101, [[None, None, None], [None, None, None]])], f"Got {res}"

    def test_search_by_industry_counts_same_as_name_only_true(self):
        res = org_uris_by_industry_id_and_or_geo_code(23, None, combine_same_as_name_only=True)
        assert res == [('https://1145.am/db/100/foo_newone', 3)]

    def test_search_by_industry_geo_counts(self):
        res = org_uris_by_industry_id_and_or_geo_code(23, 'US-OH')
        assert res == [('https://1145.am/db/100/foo_newone', 3)]
        
    def test_search_by_same_as_name_only(self):
        res = search_organizations_by_name("same_as_one",combine_same_as_name_only=True)
        assert [(x[0].uri,x[1]) for x in res] == [('https://1145.am/db/200/same_as_one', 1), 
                                                  ('https://1145.am/db/300/same_as_b_one', 1)]
    
    def test_search_without_same_as_name_only(self):
        res = search_organizations_by_name("same_as_one",combine_same_as_name_only=False)
        assert [(x[0].uri,x[1]) for x in res] == [('https://1145.am/db/200/same_as_one', 1),
                    ('https://1145.am/db/300/same_as_b_one', 1), ('https://1145.am/db/201/same_as_two', 1), 
                    ('https://1145.am/db/203/same_as_four', 1), ('https://1145.am/db/204/same_as_five', 1), 
                    ('https://1145.am/db/202/same_as_three', 1), ('https://1145.am/db/301/same_as_b_two', 1), 
                    ('https://1145.am/db/302/same_as_b_three', 1)]


class TestIgnoreLowRelativeWeightIndustryCluster(TestCase):

    def setUpTestData():
        '''
            CALL apoc.export.cypher.query( 
            'match (n: Resource&Organization)-[ic:industryClusterPrimary]->(i:Resource&IndustryCluster) where n.uri in ["https://1145.am/db/2349/Johnson_Johnson", "https://1145.am/db/870/Capital_Rx","https://1145.am/db/1759/Citigroup_Inc"] return *',
            null,
            {format: "plain", stream:true})
        '''
        clean_db()
        queries = """CREATE CONSTRAINT n10s_unique_uri IF NOT EXISTS FOR (node:Resource) REQUIRE (node.uri) IS UNIQUE;
            UNWIND [{uri:"https://1145.am/db/industry/135_pharmaceutical_research_drug_drugs", properties:{topicId:135, uniqueName:"135_pharmaceutical_research_drug_drugs", deletedRedundantSameAsAt:1, representativeDoc:["Drug Discovery And Development", "Drug Discovery Research", "Drug Development And Discovery"], representation:["toxicology", "development", "pharmaceutical", "researcher", "drugs", "discovery", "scientific", "research", "biotech", "drug"]}}, {uri:"https://1145.am/db/industry/289_bank_banking_investment_bankers", properties:{topicId:289, uniqueName:"289_bank_banking_investment_bankers", deletedRedundantSameAsAt:1, representativeDoc:["Investment Bank", "Banking And Markets Investment Bank", "Investment Bank And Financial Services Firm"], representation:["brokerage", "firm", "bank", "bankers", "banks", "financial", "investment", "banker", "finance", "banking"]}}, {uri:"https://1145.am/db/industry/426_transition_energy_renewables_renewable", properties:{topicId:426, uniqueName:"426_transition_energy_renewables_renewable", deletedRedundantSameAsAt:1, representativeDoc:["Energy Transition", "Energy Transition Business", "Energy Transition Investment Firm"], representation:["environment", "sustainable", "renewable", "fuels", "investment", "renewables", "sector", "sustainability", "transition", "energy"]}}, {uri:"https://1145.am/db/industry/290_wellness_health_healthcare_services", properties:{topicId:290, uniqueName:"290_wellness_health_healthcare_services", deletedRedundantSameAsAt:1, representativeDoc:["Health And Wellness", "Health, And Wellness", "Health-And-Wellness"], representation:["", "wellness", "health", "services", "healthcare"]}}, {uri:"https://1145.am/db/industry/269_biotech_biotechs_biotechnologies_biotechnological", properties:{topicId:269, uniqueName:"269_biotech_biotechs_biotechnologies_biotechnological", deletedRedundantSameAsAt:1, representativeDoc:["Biotech And Technology", "Biotech Products", "Biotech"], representation:["biologicals", "biotechnologies", "biotechnology", "biotechnological", "biotechs", "biolife", "medtech", "bioengineering", "biosystems", "biotech"]}}, {uri:"https://1145.am/db/industry/325_banking_financial_finance_business", properties:{topicId:325, uniqueName:"325_banking_financial_finance_business", deletedRedundantSameAsAt:1, representativeDoc:["Financial And Banking Services", "Banking And Financial Services", "Financial And Banking Sector"], representation:["sectors", "business", "financial", "industries", "industry", "services", "sector", "finance", "banking", "securities"]}}, {uri:"https://1145.am/db/industry/286_credit_private_lending_lender", properties:{topicId:286, uniqueName:"286_credit_private_lending_lender", deletedRedundantSameAsAt:1, representativeDoc:["Private Credit", "Private-Credit", "Private Credit Business"], representation:["bank", "lender", "private", "underwriting", "lending", "financing", "investment", "banker", "credit", "debt"]}}, {uri:"https://1145.am/db/industry/293_drugmaking_drugmakers_pharmaceutical_manufacturing", properties:{topicId:293, uniqueName:"293_drugmaking_drugmakers_pharmaceutical_manufacturing", deletedRedundantSameAsAt:1, representativeDoc:["Drug Substance Production", "Drug Substance Manufacturing", "Drug Substance And Drug Product Manufacturing"], representation:["drugmakers", "pharmaceutical", "pharmaceutics", "manufacturers", "drugmaking", "production", "substance", "manufacturing", "pharma", "drug"]}}, {uri:"https://1145.am/db/industry/127_lifesciences_lifescience_biosciences_biotech", properties:{topicId:127, uniqueName:"127_lifesciences_lifescience_biosciences_biotech", deletedRedundantSameAsAt:1, representativeDoc:["Life Sciences", "Life Sciences And Technology", "Life-Sciences"], representation:["biomedicines", "biosciences", "sciences", "lifescience", "biomed", "biotechnology", "bioscience", "biomedicine", "lifesciences", "biotech"]}}, {uri:"https://1145.am/db/industry/454_consumable_medspa_products_product", properties:{topicId:454, uniqueName:"454_consumable_medspa_products_product", deletedRedundantSameAsAt:1, representativeDoc:["Medical Consumable Products", "Health Products Tracing", "Healthcare Products Tracing Systems"], representation:["", "medical", "product", "tracing", "systems", "consumable", "medspa", "health", "healthcare", "products"]}}, {uri:"https://1145.am/db/industry/20_beauty_cosmetics_cosmetic_skincare", properties:{topicId:20, uniqueName:"20_beauty_cosmetics_cosmetic_skincare", deletedRedundantSameAsAt:1, representativeDoc:["Beauty", "Beauty Products", "Beauty Services"], representation:["makeup", "beautycon", "beauty", "skincare", "skin", "cosmetic", "haircare", "aesthetics", "cosmeceutical", "cosmetics"]}}, {uri:"https://1145.am/db/industry/256_investment_investments_investing_funds", properties:{topicId:256, uniqueName:"256_investment_investments_investing_funds", deletedRedundantSameAsAt:1, representativeDoc:["Fractional Investment", "Quant Firm", "Investment"], representation:["firm", "business", "fund", "financial", "investment", "funds", "firms", "investing", "investments", "quant"]}}, {uri:"https://1145.am/db/industry/114_devices_device_equipment_medical", properties:{topicId:114, uniqueName:"114_devices_device_equipment_medical", deletedRedundantSameAsAt:1, representativeDoc:["Medical Equipment And Devices", "Medical Technology Devices", "Medical Devices And Equipment"], representation:["technologies", "medical", "instruments", "devices", "devicemaker", "equipment", "technology", "biomedical", "device", "med"]}}, {uri:"https://1145.am/db/industry/705_pharmaceutical_therapeutics_drug_delivery", properties:{topicId:705, uniqueName:"705_pharmaceutical_therapeutics_drug_delivery", deletedRedundantSameAsAt:1, representativeDoc:["Drug-Delivery", "Drug Delivery", "Drug Delivery Technology"], representation:["", "delivery", "pharmaceutical", "therapeutics", "supplier", "company", "technology", "drug", "products"]}}, {uri:"https://1145.am/db/industry/702_wealth_asset_financial_investment", properties:{topicId:702, uniqueName:"702_wealth_asset_financial_investment", deletedRedundantSameAsAt:1, representativeDoc:["Wealth Asset Management", "Wealth And Asset Management", "Asset And Wealth Management"], representation:["", "wealth", "management", "financial", "investment", "asset"]}}, {uri:"https://1145.am/db/industry/638_pharmacy_pharmacies_software_technology", properties:{topicId:638, uniqueName:"638_pharmacy_pharmacies_software_technology", deletedRedundantSameAsAt:1, representativeDoc:["Pharmacy Technology", "Pharmacy Software Solutions", "Pharmacy Technology Provider"], representation:["", "tech", "automation", "software", "provider", "solutions", "pharmacy", "services", "technology", "pharmacies"]}}, {uri:"https://1145.am/db/industry/340_babycare_babywear_baby_infant", properties:{topicId:340, uniqueName:"340_babycare_babywear_baby_infant", deletedRedundantSameAsAt:1, representativeDoc:["Baby Products", "Baby Care Products", "Baby Care"], representation:["product", "strollers", "babycare", "diapers", "skincare", "baby", "infant", "nappy", "babywear", "products"]}}, {uri:"https://1145.am/db/industry/363_pharmaceutical_pharmaceuticals_devices_device", properties:{topicId:363, uniqueName:"363_pharmaceutical_pharmaceuticals_devices_device", deletedRedundantSameAsAt:1, representativeDoc:["Drug-Device Combination Development", "Drug Device Combination Product", "Drug-Device Combination Treatment"], representation:["medical", "pharmaceutical", "product", "devices", "devicemaker", "pharma", "pharmaceuticals", "device", "combination", "drug"]}}, {uri:"https://1145.am/db/industry/1_payments_payment_pay_billing", properties:{topicId:1, uniqueName:"1_payments_payment_pay_billing", deletedRedundantSameAsAt:1, representativeDoc:["Payment", "E-Payment", "Payment Technology"], representation:["payable", "chargeback", "payments", "invoicing", "merchant", "pay", "payment", "receivable", "transaction", "billing"]}}, {uri:"https://1145.am/db/industry/22_plastics_plastic_polymers_thermoplastics", properties:{topicId:22, uniqueName:"22_plastics_plastic_polymers_thermoplastics", deletedRedundantSameAsAt:1, representativeDoc:["Rubber, Foam, And Plastic Polymer Science", "Plastics", "Rubber And Plastics"], representation:["polymer", "plastic", "bioplastics", "plastics", "polystyrene", "thermoplastics", "bioplastic", "polymers", "polystyerene", "thermoplastic"]}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:IndustryCluster;
            UNWIND [{uri:"https://1145.am/db/industry/231_analytics_healthcare_data_provider", properties:{topicId:231, uniqueName:"231_analytics_healthcare_data_provider", deletedRedundantSameAsAt:1, representativeDoc:["Healthcare Data Analytics Services", "Healthcare Data And Analytics", "Healthcare Data Analytics"], representation:["", "analytics", "medical", "data", "provider", "patient", "health", "healthcare"]}}, {uri:"https://1145.am/db/industry/642_diagnostics_devices_diagnostic_medical", properties:{topicId:642, uniqueName:"642_diagnostics_devices_diagnostic_medical", deletedRedundantSameAsAt:1, representativeDoc:["Medical Devices And Diagnostics", "Medical Diagnostics And Devices", "Diagnostics And Medical Devices"], representation:["", "diagnostics", "medical", "instruments", "tests", "devices", "testing", "equipment", "diagnostic", "device"]}}, {uri:"https://1145.am/db/industry/402_credit_card_cards_consumer", properties:{topicId:402, uniqueName:"402_credit_card_cards_consumer", deletedRedundantSameAsAt:1, representativeDoc:["Credit Card", "Credit Card Business", "Credit Card Industry"], representation:["", "commercial", "cards", "business", "industry", "credit", "card", "consumer", "finance"]}}, {uri:"https://1145.am/db/industry/296_broker_brokerage_brokers_brokerages", properties:{topicId:296, uniqueName:"296_broker_brokerage_brokers_brokerages", deletedRedundantSameAsAt:1, representativeDoc:["Broker-Dealer And Alternative Trading Systems", "Broker Dealer", "Broker-Dealer"], representation:["trading", "brokerage", "brokers", "service", "dealer", "interdealer", "services", "broker", "brokerages", "securities"]}}, {uri:"https://1145.am/db/industry/63_pharma_pharmas_pharmatech_pharmaceuticals", properties:{topicId:63, uniqueName:"63_pharma_pharmas_pharmatech_pharmaceuticals", deletedRedundantSameAsAt:1, representativeDoc:["Healthcare And Pharma", "Pharma And Healthcare", "Pharma Industry"], representation:["pharmatimes", "pharmaceutica", "pharmacare", "pharmaceutical", "pharmaceutics", "pharmatech", "pharmacy", "pharmas", "pharma", "pharmaceuticals"]}}, {uri:"https://1145.am/db/industry/59_hospital_hospitals_hospitalist_healthcare", properties:{topicId:59, uniqueName:"59_hospital_hospitals_hospitalist_healthcare", deletedRedundantSameAsAt:1, representativeDoc:["Hospital Management Service", "Hospital System", "Hospital Provider"], representation:["hospitals", "medical", "management", "provider", "clinic", "hospital", "hospitalist", "healthsystem", "providers", "healthcare"]}}, {uri:"https://1145.am/db/industry/478_generic_generics_pharmaceutical_medicines", properties:{topicId:478, uniqueName:"478_generic_generics_pharmaceutical_medicines", deletedRedundantSameAsAt:1, representativeDoc:["Generic", "Generic Products", "Generic-Drug"], representation:["pharmaceutical", "medicines", "generics", "meds", "drugs", "prescription", "pharmaceuticals", "generic", "drug", "products"]}}, {uri:"https://1145.am/db/industry/118_data_financial_finance_investors", properties:{topicId:118, uniqueName:"118_data_financial_finance_investors", deletedRedundantSameAsAt:1, representativeDoc:["Financial Data", "Financial-Data", "Financial Data Services"], representation:["analytics", "technologies", "data", "financial", "investment", "charting", "investing", "technology", "investors", "finance"]}}, {uri:"https://1145.am/db/industry/28_biopharmaceutical_biopharmaceuticals_bioceutical_biopharma", properties:{topicId:28, uniqueName:"28_biopharmaceutical_biopharmaceuticals_bioceutical_biopharma", deletedRedundantSameAsAt:1, representativeDoc:["Biotechnology And Biopharmaceutical", "Biopharmaceutical Biotechnology", "Biopharmaceutical And Biotech Industry"], representation:["biotherapeutics", "biopharmas", "bioceutical", "biopharma", "biotechnology", "biopharmaceuticals", "biotechs", "biopharmaceutical", "biotechnolgy", "biotech"]}}, {uri:"https://1145.am/db/industry/282_gastrointestinal_gastroenterology_gi_endoscopic", properties:{topicId:282, uniqueName:"282_gastrointestinal_gastroenterology_gi_endoscopic", deletedRedundantSameAsAt:1, representativeDoc:["Gastrointestinal Device Market", "Gastrointestinal Health", "Gastrointestinal Device"], representation:["endoscopic", "gastrointestinal", "gi", "medical", "devicemakers", "endoscopy", "gastroenterology", "implant", "device", "med"]}}, {uri:"https://1145.am/db/industry/578_pharmacy_benefit_benefits_pharmaceutical", properties:{topicId:578, uniqueName:"578_pharmacy_benefit_benefits_pharmaceutical", deletedRedundantSameAsAt:1, representativeDoc:["Pharmacy Benefit Management Services", "Pharmacy Benefit", "Pharmacy Benefit Management"], representation:["", "benefits", "pharmaceutical", "rebate", "pharmacy", "services", "benefit"]}}, {uri:"https://1145.am/db/industry/101_banks_banking_bank_bankers", properties:{topicId:101, uniqueName:"101_banks_banking_bank_bankers", deletedRedundantSameAsAt:1, representativeDoc:["Savings Banks", "Commercial Banks", "Community Banks"], representation:["bank", "commercialbanking", "bankers", "banks", "bancassurer", "bancorporation", "banco", "bancorp", "banker", "banking"]}}, {uri:"https://1145.am/db/industry/72_consumer_retail_household_commercial", properties:{topicId:72, uniqueName:"72_consumer_retail_household_commercial", deletedRedundantSameAsAt:1, representativeDoc:["Consumer", "Consumer Business", "Consumer Services"], representation:["commercial", "retailer", "service", "industries", "household", "services", "commerce", "businesses", "consumer", "retail"]}}, {uri:"https://1145.am/db/industry/109_ophthalmic_ophthalmologic_ophthalmology_eyecare", properties:{topicId:109, uniqueName:"109_ophthalmic_ophthalmologic_ophthalmology_eyecare", deletedRedundantSameAsAt:1, representativeDoc:["Ophthalmic Services", "Ophthalmic Lens And Eyewear", "Ophthalmic"], representation:["eye", "ophthalmologic", "eyewear", "ophthalmic", "optometric", "ophthalmology", "eyeglass", "eyeglasses", "optometry", "eyecare"]}}, {uri:"https://1145.am/db/industry/235_agetech_caretech_heathtech_tech", properties:{topicId:235, uniqueName:"235_agetech_caretech_heathtech_tech", deletedRedundantSameAsAt:1, representativeDoc:["Agetech", "Age-Tech", "Caretech"], representation:["", "agetech", "tech", "technologies", "caretech", "health", "technology", "heathtech", "age", "healthcare"]}}, {uri:"https://1145.am/db/industry/112_imaging_radiology_medical_tomography", properties:{topicId:112, uniqueName:"112_imaging_radiology_medical_tomography", deletedRedundantSameAsAt:1, representativeDoc:["Medical Imaging Solutions", "Medical Imaging Technology", "Medical Imaging"], representation:["image", "diagnostics", "images", "medical", "radiology", "tomography", "diagnostic", "technology", "imaging", "ultrasound"]}}, {uri:"https://1145.am/db/industry/742_techmed_med_medical_tech", properties:{topicId:742, uniqueName:"742_techmed_med_medical_tech", deletedRedundantSameAsAt:1, representativeDoc:["Med-Tech", "Med Tech And Technology", "Hypromag Has Licensed The Patented Technology Called Hpms"], representation:["tech", "clinical", "hypromag", "medical", "patented", "advancements", "techmed", "technology", "med", "hpms"]}}, {uri:"https://1145.am/db/industry/261_wholesale_wholesaler_wholesalers_distributor", properties:{topicId:261, uniqueName:"261_wholesale_wholesaler_wholesalers_distributor", deletedRedundantSameAsAt:1, representativeDoc:["Food Wholesale", "Wholesale Business", "Wholesale"], representation:["market", "wholesale", "wholesalers", "retailer", "goods", "selling", "store", "wholesaler", "distributor", "retail"]}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:IndustryCluster;
            UNWIND [{uri:"https://1145.am/db/2349/Johnson_Johnson", properties:{basedInHighClean:["United States"], internalDocId:2349, deletedRedundantSameAsAt:1, foundName:["Johnson & Johnson"], name:["Johnson & Johnson"], description:["healthcare"], industry:["healthcare"], basedInHighRaw:["U.S."]}}, {uri:"https://1145.am/db/870/Capital_Rx", properties:{internalDocId:870, deletedRedundantSameAsAt:1, foundName:["Capital Rx"], name:["Capital Rx"], description:["health insurance and healthcare technologies"], industry:["pharmacy benefits"], basedInLowRaw:["UnitedHealth Group's northeast division"]}}, {uri:"https://1145.am/db/1759/Citigroup_Inc", properties:{internalDocId:1759, deletedRedundantSameAsAt:1, foundName:["Citigroup Inc", "Citi"], name:["Citigroup Inc", "Citi"], description:["U.S. bank", "financial sectors"], industry:["bank", "financial"], basedInLowRaw:["China", "U.S"]}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Organization;
            UNWIND [{start: {uri:"https://1145.am/db/870/Capital_Rx"}, end: {uri:"https://1145.am/db/industry/578_pharmacy_benefit_benefits_pharmaceutical"}, properties:{weight:3}}, {start: {uri:"https://1145.am/db/1759/Citigroup_Inc"}, end: {uri:"https://1145.am/db/industry/118_data_financial_finance_investors"}, properties:{weight:13}}, {start: {uri:"https://1145.am/db/1759/Citigroup_Inc"}, end: {uri:"https://1145.am/db/industry/101_banks_banking_bank_bankers"}, properties:{weight:239}}, {start: {uri:"https://1145.am/db/870/Capital_Rx"}, end: {uri:"https://1145.am/db/industry/59_hospital_hospitals_hospitalist_healthcare"}, properties:{weight:4}}, {start: {uri:"https://1145.am/db/870/Capital_Rx"}, end: {uri:"https://1145.am/db/industry/235_agetech_caretech_heathtech_tech"}, properties:{weight:3}}, {start: {uri:"https://1145.am/db/870/Capital_Rx"}, end: {uri:"https://1145.am/db/industry/63_pharma_pharmas_pharmatech_pharmaceuticals"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/870/Capital_Rx"}, end: {uri:"https://1145.am/db/industry/638_pharmacy_pharmacies_software_technology"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/1759/Citigroup_Inc"}, end: {uri:"https://1145.am/db/industry/72_consumer_retail_household_commercial"}, properties:{weight:3}}, {start: {uri:"https://1145.am/db/1759/Citigroup_Inc"}, end: {uri:"https://1145.am/db/industry/289_bank_banking_investment_bankers"}, properties:{weight:25}}, {start: {uri:"https://1145.am/db/1759/Citigroup_Inc"}, end: {uri:"https://1145.am/db/industry/1_payments_payment_pay_billing"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/1759/Citigroup_Inc"}, end: {uri:"https://1145.am/db/industry/325_banking_financial_finance_business"}, properties:{weight:8}}, {start: {uri:"https://1145.am/db/1759/Citigroup_Inc"}, end: {uri:"https://1145.am/db/industry/286_credit_private_lending_lender"}, properties:{weight:2}}, {start: {uri:"https://1145.am/db/1759/Citigroup_Inc"}, end: {uri:"https://1145.am/db/industry/702_wealth_asset_financial_investment"}, properties:{weight:2}}, {start: {uri:"https://1145.am/db/1759/Citigroup_Inc"}, end: {uri:"https://1145.am/db/industry/402_credit_card_cards_consumer"}, properties:{weight:2}}, {start: {uri:"https://1145.am/db/1759/Citigroup_Inc"}, end: {uri:"https://1145.am/db/industry/296_broker_brokerage_brokers_brokerages"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/1759/Citigroup_Inc"}, end: {uri:"https://1145.am/db/industry/256_investment_investments_investing_funds"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/63_pharma_pharmas_pharmatech_pharmaceuticals"}, properties:{weight:846}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/340_babycare_babywear_baby_infant"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/742_techmed_med_medical_tech"}, properties:{weight:9}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/112_imaging_radiology_medical_tomography"}, properties:{weight:1}}] AS row
            MATCH (start:Resource{uri: row.start.uri})
            MATCH (end:Resource{uri: row.end.uri})
            CREATE (start)-[r:industryClusterPrimary]->(end) SET r += row.properties;
            UNWIND [{start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/114_devices_device_equipment_medical"}, properties:{weight:89}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/235_agetech_caretech_heathtech_tech"}, properties:{weight:2}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/642_diagnostics_devices_diagnostic_medical"}, properties:{weight:7}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/282_gastrointestinal_gastroenterology_gi_endoscopic"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/269_biotech_biotechs_biotechnologies_biotechnological"}, properties:{weight:9}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/20_beauty_cosmetics_cosmetic_skincare"}, properties:{weight:2}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/231_analytics_healthcare_data_provider"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/290_wellness_health_healthcare_services"}, properties:{weight:7}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/72_consumer_retail_household_commercial"}, properties:{weight:27}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/478_generic_generics_pharmaceutical_medicines"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/22_plastics_plastic_polymers_thermoplastics"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/28_biopharmaceutical_biopharmaceuticals_bioceutical_biopharma"}, properties:{weight:3}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/127_lifesciences_lifescience_biosciences_biotech"}, properties:{weight:3}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/705_pharmaceutical_therapeutics_drug_delivery"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/135_pharmaceutical_research_drug_drugs"}, properties:{weight:7}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/261_wholesale_wholesaler_wholesalers_distributor"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/363_pharmaceutical_pharmaceuticals_devices_device"}, properties:{weight:5}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/454_consumable_medspa_products_product"}, properties:{weight:15}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/293_drugmaking_drugmakers_pharmaceutical_manufacturing"}, properties:{weight:74}}, {start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/109_ophthalmic_ophthalmologic_ophthalmology_eyecare"}, properties:{weight:1}}] AS row
            MATCH (start:Resource{uri: row.start.uri})
            MATCH (end:Resource{uri: row.end.uri})
            CREATE (start)-[r:industryClusterPrimary]->(end) SET r += row.properties;
            UNWIND [{start: {uri:"https://1145.am/db/2349/Johnson_Johnson"}, end: {uri:"https://1145.am/db/industry/59_hospital_hospitals_hospitalist_healthcare"}, properties:{weight:163}}, {start: {uri:"https://1145.am/db/1759/Citigroup_Inc"}, end: {uri:"https://1145.am/db/industry/426_transition_energy_renewables_renewable"}, properties:{weight:1}}] AS row
            MATCH (start:Resource{uri: row.start.uri})
            MATCH (end:Resource{uri: row.end.uri})
            CREATE (start)-[r:industryClusterPrimary]->(end) SET r += row.properties;""".split(";")
        for query in queries:
            if query is None or query.strip() == "":
                continue
            db.cypher_query(query)
        R = RDFPostProcessor()
        R.run_all_in_order()
        refresh_geo_data(fill_blanks=False)

    def test_does_not_find_org_with_low_relative_weight(self):
        ind_id = 235 #"https://1145.am/db/industry/235_agetech_caretech_heathtech_tech"
        query = f"MATCH (i: Resource&IndustryCluster {{topicId:{ind_id}}})-[ic:industryClusterPrimary]-(o: Organization) return o.uri, ic.weight"
        res, _ = db.cypher_query(query)
        as_set = set( [tuple(x) for x in res])
        assert as_set == {('https://1145.am/db/2349/Johnson_Johnson', 2), ('https://1145.am/db/870/Capital_Rx', 3)} # J&J sum weight = 1277
        caretech_uris = org_uris_by_industry_id_and_or_geo_code(235, None)
        assert set([x[0] for x in caretech_uris]) == {'https://1145.am/db/870/Capital_Rx'}               
        
    def test_org_does_not_include_low_weight_industries(self):
        query="MATCH (o: Resource&Organization {uri:'https://1145.am/db/2349/Johnson_Johnson'})-[ic:industryClusterPrimary]->(i:IndustryCluster) RETURN o.uri, ic.weight, i.uri"
        res, _ = db.cypher_query(query)
        sum_of_weights = sum([x[1] for x in res])
        high_weight_matches = [x[2] for x in res if x[1] >= INDUSTRY_CLUSTER_MIN_WEIGHT_PROPORTION * sum_of_weights]
        low_weight_matches = [x[2] for x in res if x[1] < INDUSTRY_CLUSTER_MIN_WEIGHT_PROPORTION * sum_of_weights]
        org = Resource.get_by_uri('https://1145.am/db/2349/Johnson_Johnson')
        all_based_in_uris = [x.uri for x in org.internal_industryClusterPrimary]
        assert set(all_based_in_uris) == set(high_weight_matches + low_weight_matches)
        high_weight_based_in_uris = [x.uri for x in org.industryClusterPrimary]
        assert set(high_weight_based_in_uris) == set(high_weight_matches)


class TestIgnoreLowRelativeWeightGeoLocations(TestCase):

    def setUpTestData():
        '''
            Based on
            CALL apoc.export.cypher.query( 
            'match (o: Resource&Organization)-[b:basedInHighGeoNamesLocation]-(l: Resource&GeoNamesLocation), (o)-[:documentSource]->(a: Resource&Article), (l)-[:documentSource]->(a) where o.uri in ["https://1145.am/db/88496/Exelixis_Inc","https://1145.am/db/90949/Moderna","https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"] return *',
            null,
            {format: "plain", stream:true})
        '''
        clean_db()
        queries = """CREATE CONSTRAINT n10s_unique_uri IF NOT EXISTS FOR (node:Resource) REQUIRE (node.uri) IS UNIQUE;
            UNWIND [{uri:"https://1145.am/db/geonames_location/4930956", properties:{featureCode:"PPLA", deletedRedundantSameAsAt:1, countryCode:"US", name:["Boston"], geoNamesId:4930956, admin1Code:"MA"}}, {uri:"https://1145.am/db/geonames_location/5380748", properties:{featureCode:"PPL", deletedRedundantSameAsAt:1, countryCode:"US", name:["Palo Alto"], geoNamesId:5380748, admin1Code:"CA"}}, {uri:"https://1145.am/db/geonames_location/4464368", properties:{featureCode:"PPLA2", deletedRedundantSameAsAt:1, countryCode:"US", name:["Durham"], geoNamesId:4464368, admin1Code:"NC"}}, {uri:"https://1145.am/db/geonames_location/3042142", properties:{featureCode:"PCL", deletedRedundantSameAsAt:1, countryCode:"JE", name:["Bailiwick of Jersey"], geoNamesId:3042142, admin1Code:"00"}}, {uri:"https://1145.am/db/geonames_location/2643743", properties:{featureCode:"PPLC", deletedRedundantSameAsAt:1, countryCode:"GB", name:["London"], geoNamesId:2643743, admin1Code:"ENG"}}, {uri:"https://1145.am/db/geonames_location/6251999", properties:{featureCode:"PCLI", deletedRedundantSameAsAt:1, countryCode:"CA", name:["Canada"], geoNamesId:6251999, admin1Code:"00"}}, {uri:"https://1145.am/db/geonames_location/2077456", properties:{featureCode:"PCLI", deletedRedundantSameAsAt:1, countryCode:"AU", name:["Commonwealth of Australia"], geoNamesId:2077456, admin1Code:"00"}}, {uri:"https://1145.am/db/geonames_location/6252001", properties:{featureCode:"PCLI", deletedRedundantSameAsAt:1, countryCode:"US", name:["United States"], geoNamesId:6252001, admin1Code:"00"}}, {uri:"https://1145.am/db/geonames_location/1645457", properties:{featureCode:"PPLC", deletedRedundantSameAsAt:1, countryCode:"TL", name:["Dili"], geoNamesId:1645457, admin1Code:"DI"}}, {uri:"https://1145.am/db/geonames_location/5391959", properties:{featureCode:"PPLA2", deletedRedundantSameAsAt:1, countryCode:"US", name:["San Francisco"], geoNamesId:5391959, admin1Code:"CA"}}, {uri:"https://1145.am/db/geonames_location/5128581", properties:{featureCode:"PPL", deletedRedundantSameAsAt:1, countryCode:"US", name:["New York City"], geoNamesId:5128581, admin1Code:"NY"}}, {uri:"https://1145.am/db/geonames_location/2635167", properties:{featureCode:"PCLI", deletedRedundantSameAsAt:1, countryCode:"GB", name:["United Kingdom of Great Britain and Northern Ireland"], geoNamesId:2635167, admin1Code:"00"}}, {uri:"https://1145.am/db/geonames_location/3993763", properties:{featureCode:"PPLA2", deletedRedundantSameAsAt:1, countryCode:"MX", name:["Palo Alto"], geoNamesId:3993763, admin1Code:"01"}}, {uri:"https://1145.am/db/geonames_location/5397765", properties:{featureCode:"PPL", deletedRedundantSameAsAt:1, countryCode:"US", name:["South San Francisco"], geoNamesId:5397765, admin1Code:"CA"}}, {uri:"https://1145.am/db/geonames_location/2964574", properties:{featureCode:"PPLC", deletedRedundantSameAsAt:1, countryCode:"IE", name:["Dublin"], geoNamesId:2964574, admin1Code:"L"}}, {uri:"https://1145.am/db/geonames_location/6254926", properties:{featureCode:"ADM1", deletedRedundantSameAsAt:1, countryCode:"US", name:["Massachusetts"], geoNamesId:6254926, admin1Code:"MA"}}, {uri:"https://1145.am/db/geonames_location/4931972", properties:{featureCode:"PPL", deletedRedundantSameAsAt:1, countryCode:"US", name:["Cambridge"], geoNamesId:4931972, admin1Code:"MA"}}, {uri:"https://1145.am/db/geonames_location/2963597", properties:{featureCode:"PCLI", deletedRedundantSameAsAt:1, countryCode:"IE", name:["Ireland"], geoNamesId:2963597, admin1Code:"00"}}, {uri:"https://1145.am/db/geonames_location/5322737", properties:{featureCode:"PPL", deletedRedundantSameAsAt:1, countryCode:"US", name:["Alameda"], geoNamesId:5322737, admin1Code:"CA"}}, {uri:"https://1145.am/db/geonames_location/4192205", properties:{featureCode:"PPLA2", deletedRedundantSameAsAt:1, countryCode:"US", name:["Dublin"], geoNamesId:4192205, admin1Code:"GA"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:GeoNamesLocation;
            UNWIND [{uri:"https://1145.am/db/geonames_location/4887398", properties:{featureCode:"PPLA2", deletedRedundantSameAsAt:1, countryCode:"US", name:["Chicago"], geoNamesId:4887398, admin1Code:"IL"}}, {uri:"https://1145.am/db/geonames_location/4158928", properties:{featureCode:"PPL", deletedRedundantSameAsAt:1, countryCode:"US", name:["Hollywood"], geoNamesId:4158928, admin1Code:"FL"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:GeoNamesLocation;
            UNWIND [{uri:"https://1145.am/db/88496/Exelixis_Inc", properties:{basedInHighClean:["Alameda"], internalDocId:88496, deletedRedundantSameAsAt:1, foundName:["Exelixis Inc", "Exelixis"], name:["Exelixis Inc"], description:["Pharmaceuticals"], industry:["drug developer"], basedInLowRaw:["United States"], basedInHighRaw:["Alameda, California"]}}, {uri:"https://1145.am/db/90949/Moderna", properties:{internalDocId:90949, deletedRedundantSameAsAt:1, foundName:["Moderna, Inc", "Moderna"], name:["Moderna"], description:["Biotechnology"], industry:["biotechnology"], internalMergedSameAsHighToUri:"https://1145.am/db/87262/Moderna"}}, {uri:"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc", properties:{basedInHighClean:["Dublin"], internalDocId:88387, deletedRedundantSameAsAt:1, foundName:["Jazz", "Jazz Pharmaceuticals PLC"], name:["Jazz Pharmaceuticals PLC"], industry:["Pharmaceuticals"], basedInLowRaw:["United States"], basedInHighRaw:["Dublin"]}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Organization;
            UNWIND [{uri:"https://1145.am/db/2370560/wwwfiercebiotechcom_biotech_exelixis-exel-announces-key-senior-leadership-hires-medical-affairs-sales-and-marketing-to", properties:{datePublished:datetime('2015-09-25T12:53:31Z'), internalDocId:2370560, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis (EXEL) Announces Key Senior Leadership Hires In Medical Affairs, Sales, And Marketing To Support Commercialization Of Cabozantinib And Cobimetinib"}}, {uri:"https://1145.am/db/934888/apnewscom_press-release_GlobeNewswire_business-health-mental-health-sleep-apnea-migraine-b9a089b7a81d5a0cb805c292fd947a1d", properties:{datePublished:datetime('2022-03-28T10:02:44Z'), internalDocId:934888, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Axsome Therapeutics to Acquire Sunosi from Jazz Pharmaceuticals, Expanding Axsome's Leadership in Neuroscience"}}, {uri:"https://1145.am/db/3567722/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-appointment-of-anne-oriordan-to-its-board-of-directors-300796202html", properties:{datePublished:datetime('2019-02-14T21:05:00Z'), internalDocId:3567722, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-17T19:35:10Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Appointment of Anne O'Riordan to its Board of Directors"}}, {uri:"https://1145.am/db/2557428/wwwfiercepharmacom_pharma_gearing-up-for-commercial-ops-moderna-recruits-amgen-vet-meline-as-cfo", properties:{datePublished:datetime('2020-06-04T15:14:58Z'), internalDocId:2557428, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Gearing up for commercial ops, Moderna recruits Amgen vet Meline as CFO"}}, {uri:"https://1145.am/db/1042008/apnewscom_press-release_GlobeNewswire_business-health-sleep-disorders-apnea-narcolepsy-f2b39aed5c017a2b7b9f1b33232980b9", properties:{datePublished:datetime('2022-05-09T13:02:56Z'), internalDocId:1042008, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Axsome Therapeutics Completes U.S. Acquisition of Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea"}}, {uri:"https://1145.am/db/2563661/wwwfiercepharmacom_pharma_moderna-lures-novartis-top-lawyer-to-be-its-own-as-covid-19-vaccine-rollout-raises-legal", properties:{datePublished:datetime('2021-03-08T16:00:00Z'), internalDocId:2563661, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Moderna lures Novartis' top lawyer to be its own as COVID-19 vaccine rollout raises legal risks"}}, {uri:"https://1145.am/db/1514071/apnewscom_press-release_accesswire_health-business-covid-5891a8e2ea0496fdef99b0054c400e6e", properties:{datePublished:datetime('2022-11-17T13:11:36Z'), internalDocId:1514071, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"David Jimnez Joins Moderna As U.S. General Manager"}}, {uri:"https://1145.am/db/3717517/seekingalphacom_news_4045416-moderna-ceo-lead-sales-commercial-chief-departs", properties:{datePublished:datetime('2023-12-12T13:27:09Z'), internalDocId:3717517, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T12:26:58Z'), sourceOrganization:"Seeking Alpha", headline:"Moderna CEO to lead sales as commercial chief departs"}}, {uri:"https://1145.am/db/3640637/seekingalphacom_news_4041193-generation-bio-announces-layoffs-business-reorganization", properties:{datePublished:datetime('2023-11-29T15:16:55Z'), internalDocId:3640637, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T07:58:01Z'), sourceOrganization:"Seeking Alpha", headline:"Generation Bio cuts 40% of staff in business reorganization"}}, {uri:"https://1145.am/db/4236941/seekingalphacom_news_4088927-moderna-pauses-plans-kenya-vaccine-plant", properties:{datePublished:datetime('2024-04-11T13:24:54Z'), internalDocId:4236941, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-05-13T12:14:26Z'), sourceOrganization:"Seeking Alpha", headline:"Moderna pauses plans for Kenya vaccine plant (NASDAQ:MRNA)"}}, {uri:"https://1145.am/db/2319682/wwwfiercebiotechcom_biotech_press-release-jazz-pharmaceuticals-announces-ipo", properties:{datePublished:datetime('2007-06-01T15:07:56Z'), internalDocId:2319682, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Press release: Jazz Pharmaceuticals Announces IPO"}}, {uri:"https://1145.am/db/2351610/wwwfiercebiotechcom_biotech_jazz-pharma-basks-praise-as-it-adds-cns-drugs-azur-acquisition", properties:{datePublished:datetime('2011-09-20T15:42:48Z'), internalDocId:2351610, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharma basks in praise as it adds CNS drugs in Azur acquisition"}}, {uri:"https://1145.am/db/2344386/wwwfiercebiotechcom_r-d_exelixis-tanks-on-major-stock-and-debt-sales", properties:{datePublished:datetime('2012-08-07T15:59:25Z'), internalDocId:2344386, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis tanks on major stock and debt sales"}}, {uri:"https://1145.am/db/2354353/wwwfiercebiotechcom_r-d_biotech-upstart-moderna-nails-down-40m-for-bold-rna-idea", properties:{datePublished:datetime('2012-12-06T05:03:44Z'), internalDocId:2354353, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Biotech upstart Moderna nails down $40M for bold RNA idea"}}, {uri:"https://1145.am/db/2155125/wwwfiercebiotechcom_biotech_moderna-shoots-for-500m-ipo-biggest-biotech-history", properties:{datePublished:datetime('2018-11-10T00:55:05Z'), internalDocId:2155125, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Moderna shoots for $500M IPO, the biggest in biotech history"}}, {uri:"https://1145.am/db/2154688/wwwfiercebiotechcom_biotech_moderna-s-cash-juggernaut-rolls-record-604m-ipo", properties:{datePublished:datetime('2018-12-07T14:07:49Z'), internalDocId:2154688, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Moderna's cash juggernaut rolls on with record $604M IPO"}}, {uri:"https://1145.am/db/3060848/wwwcityamcom_david-beckham-backed-cannabis-firm-on-course-to-become-lses-first-cbd-listing", properties:{datePublished:datetime('2021-02-04T13:00:00Z'), internalDocId:3060848, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2023-12-20T05:41:42Z'), sourceOrganization:"CityAM", headline:"David Beckham-backed cannabis firm on course to become LSE's first CBD listing"}}, {uri:"https://1145.am/db/2329765/wwwfiercebiotechcom_biotech_press-release-exelixis-signs-co-development-agreement-genentech", properties:{datePublished:datetime('2007-01-03T15:25:26Z'), internalDocId:2329765, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Press Release: Exelixis Signs Co-Development Agreement With Genentech"}}, {uri:"https://1145.am/db/2328316/wwwfiercebiotechcom_biotech_antares-jazz-ink-16-5m-cns-deal", properties:{datePublished:datetime('2007-07-20T10:59:54Z'), internalDocId:2328316, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Antares, Jazz ink $16.5M CNS deal"}}, {uri:"https://1145.am/db/2301942/wwwfiercebiotechcom_biotech_press-release-glaxosmithkline-accelerates-review-of-exelixis-xl880", properties:{datePublished:datetime('2007-08-23T13:11:01Z'), internalDocId:2301942, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"PRESS RELEASE: GlaxoSmithKline Accelerates Review of Exelixis' XL880"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{uri:"https://1145.am/db/2307047/wwwfiercebiotechcom_biotech_press-release-exelixis-and-bristol-myers-squibb-extend-research-deal", properties:{datePublished:datetime('2007-09-21T15:29:28Z'), internalDocId:2307047, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"PRESS RELEASE: Exelixis and Bristol-Myers Squibb Extend Research Deal"}}, {uri:"https://1145.am/db/2324466/wwwfiercebiotechcom_biotech_press-release-exelixis-to-receive-milestone-payment-from-bristol-myers-squibb", properties:{datePublished:datetime('2007-11-29T17:57:35Z'), internalDocId:2324466, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"PRESS RELEASE: Exelixis to Receive Milestone Payment From Bristol-Myers Squibb"}}, {uri:"https://1145.am/db/2329868/wwwfiercebiotechcom_biotech_glaxosmithkline-via-its-center-of-excellence-for-external-drug-discovery-exercises-its", properties:{datePublished:datetime('2007-12-14T15:18:54Z'), internalDocId:2329868, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"GlaxoSmithKline, Via Its Center of Excellence for External Drug Discovery, Exercises Its Option to Further Develop and Commercia"}}, {uri:"https://1145.am/db/2305680/wwwfiercebiotechcom_biotech_exelixis-and-glaxosmithkline-agree-to-successfully-conclude-six-year-discovery-and", properties:{datePublished:datetime('2008-06-27T14:59:33Z'), internalDocId:2305680, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration"}}, {uri:"https://1145.am/db/2302187/wwwfiercebiotechcom_biotech_exelixis-says-glaxosmithkline-collaboration-to-end", properties:{datePublished:datetime('2008-10-23T14:37:39Z'), internalDocId:2302187, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Says GlaxoSmithKline Collaboration to End"}}, {uri:"https://1145.am/db/2304714/wwwfiercebiotechcom_biotech_exelixis-research-collaboration-bristol-myers-squibb-extended", properties:{datePublished:datetime('2008-11-06T15:41:51Z'), internalDocId:2304714, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Research Collaboration With Bristol-Myers Squibb Extended"}}, {uri:"https://1145.am/db/2302181/wwwfiercebiotechcom_biotech_exelixis-retains-rights-to-develop-and-commercialize-xl184", properties:{datePublished:datetime('2008-10-23T14:24:46Z'), internalDocId:2302181, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Retains Rights to Develop and Commercialize XL184"}}, {uri:"https://1145.am/db/2304749/wwwfiercebiotechcom_biotech_exelixis-research-collaboration-bristol-myers-squibb-extended-collaboration-focuses-on", properties:{datePublished:datetime('2008-11-10T13:47:00Z'), internalDocId:2304749, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Research Collaboration With Bristol-Myers Squibb Extended Collaboration Focuses on Novel Cardiovascular, Metabolic Ther"}}, {uri:"https://1145.am/db/2319725/wwwfiercebiotechcom_biotech_exelixis-boehringer-enter-354m-autoimmune-pact", properties:{datePublished:datetime('2009-05-08T13:42:13Z'), internalDocId:2319725, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis, Boehringer enter $354M autoimmune pact"}}, {uri:"https://1145.am/db/2319714/wwwfiercebiotechcom_biotech_exelixis-and-boehringer-ingelheim-enter-into-collaboration-for-development-of-s1p1-receptor", properties:{datePublished:datetime('2009-05-08T12:38:53Z'), internalDocId:2319714, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis and Boehringer Ingelheim Enter into Collaboration for Development of S1P1 Receptor Agonists in the Field of Autoimmune"}}, {uri:"https://1145.am/db/2324063/wwwfiercebiotechcom_biotech_exelixis-and-sanofi-aventis-sign-global-license-agreement-for-xl147-xl765-and-launch-broad", properties:{datePublished:datetime('2009-05-28T11:32:59Z'), internalDocId:2324063, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"EXELIXIS AND SANOFI-AVENTIS SIGN GLOBAL LICENSE AGREEMENT FOR XL147 & XL765 AND LAUNCH BROAD COLLABORATION FOR DISCOVERY OF PI3K"}}, {uri:"https://1145.am/db/2365222/wwwfiercebiotechcom_biotech_exelixis-regains-full-rights-to-develop-and-commercialize-xl184", properties:{datePublished:datetime('2010-06-21T14:47:32Z'), internalDocId:2365222, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Regains Full Rights to Develop and Commercialize XL184"}}, {uri:"https://1145.am/db/2367123/wwwfiercebiotechcom_biotech_exelixis-licenses-programs-to-bristol-myers-squibb-company", properties:{datePublished:datetime('2010-10-11T13:48:25Z'), internalDocId:2367123, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Licenses Programs to Bristol-Myers Squibb Company"}}, {uri:"https://1145.am/db/2350528/wwwfiercebiotechcom_biotech_exelixis-licenses-pi3k-delta-program-to-merck-0", properties:{datePublished:datetime('2011-12-21T12:49:41Z'), internalDocId:2350528, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Licenses PI3K-Delta Program to Merck"}}, {uri:"https://1145.am/db/2350516/wwwfiercebiotechcom_biotech_exelixis-licenses-pi3k-delta-program-to-merck-1", properties:{datePublished:datetime('2011-12-21T11:20:41Z'), internalDocId:2350516, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Licenses PI3K-Delta Program to Merck"}}, {uri:"https://1145.am/db/2351611/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-and-azur-pharma-agree-to-combine-to-form-jazz-pharmaceuticals-plc", properties:{datePublished:datetime('2011-09-20T15:55:24Z'), internalDocId:2351611, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals and Azur Pharma Agree to Combine to Form Jazz Pharmaceuticals plc"}}, {uri:"https://1145.am/db/2367935/wwwfiercebiotechcom_biotech_exelixis-provides-update-on-genentech-s-pending-new-drug-application-for-cobimetinib-an", properties:{datePublished:datetime('2015-07-01T15:03:24Z'), internalDocId:2367935, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Provides Update on Genentech's Pending New Drug Application for Cobimetinib, an Exelixis-Discovered Compound"}}, {uri:"https://1145.am/db/2548593/wwwfiercepharmacom_manufacturing_jazz-pharmaceuticals-breaks-ground-on-new-manufacturing-and-development-facility", properties:{datePublished:datetime('2014-02-10T16:16:35Z'), internalDocId:2548593, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz Pharmaceuticals Breaks Ground On New Manufacturing And Development Facility In Ireland"}}, {uri:"https://1145.am/db/2548596/wwwfiercepharmacom_supply-chain_jazz-investing-up-to-68m-to-build-its-first-manufacturing-facility", properties:{datePublished:datetime('2014-02-10T17:18:15Z'), internalDocId:2548596, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz is investing up to $68M to build its first manufacturing facility"}}, {uri:"https://1145.am/db/3781538/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-and-md-anderson-cancer-center-collaborate-to-evaluate-potential-treatment-options-for-hematologic-malignancies-300692580html", properties:{datePublished:datetime('2018-08-06T20:15:00Z'), internalDocId:3781538, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T17:59:25Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals and MD Anderson Cancer Center Collaborate to Evaluate Potential Treatment Options for Hematologic Malignancies"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{uri:"https://1145.am/db/3428795/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-and-codiak-biosciences-announce-strategic-collaboration-to-research-develop-and-commercialize-engineered-exosomes-to-create-therapies-for-hard-to-treat-cancers-300772647html", properties:{datePublished:datetime('2019-01-03T21:05:00Z'), internalDocId:3428795, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-17T15:57:43Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals and Codiak BioSciences Announce Strategic Collaboration to Research, Develop and Commercialize Engineered Exosomes to Create Therapies for Hard-to-Treat Cancers"}}, {uri:"https://1145.am/db/224813/wwwreuterscom_article_merck-biontech-lipids-idUSL8N2KB29S", properties:{datePublished:datetime('2021-02-05T10:17:20Z'), internalDocId:224813, deletedRedundantSameAsAt:1, sourceOrganization:"Reuters", headline:"Germany's Merck boosts BioNTech lipid supply amid vaccine shortages"}}, {uri:"https://1145.am/db/2358869/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-and-azur-pharma-combine-to-create-jazz-pharmaceuticals-plc", properties:{datePublished:datetime('2012-01-18T17:09:34Z'), internalDocId:2358869, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals and Azur Pharma Combine to Create Jazz Pharmaceuticals plc"}}, {uri:"https://1145.am/db/457686/wwwbusinesswirecom_news_home_20210908005677_en_Resilience-to-Manufacture-mRNA-for-Moderna_E2_80_99s-COVID-19-Vaccine", properties:{datePublished:datetime('2021-09-08T12:13:00Z'), internalDocId:457686, deletedRedundantSameAsAt:1, sourceOrganization:"Business Wire", headline:"Resilience to Manufacture mRNA for Moderna's COVID-19 Vaccine"}}, {uri:"https://1145.am/db/457648/wwwbusinesswirecom_news_home_20210908005443_en_Resilience-to-Manufacture-mRNA-for-Moderna_E2_80_99s-COVID-19-Vaccine", properties:{datePublished:datetime('2021-09-08T12:05:00Z'), internalDocId:457648, deletedRedundantSameAsAt:1, sourceOrganization:"Business Wire", headline:"Resilience to Manufacture mRNA for Moderna's COVID-19 Vaccine"}}, {uri:"https://1145.am/db/2551505/wwwfiercepharmacom_manufacturing_jazz-pharmaceuticals-enters-definitive-agreement-to-acquire-eusa-pharma", properties:{datePublished:datetime('2012-04-26T21:11:12Z'), internalDocId:2551505, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma"}}, {uri:"https://1145.am/db/2353565/wwwfiercebiotechcom_financials_jazz-pharmaceuticals-enters-definitive-agreement-to-acquire-eusa-pharma", properties:{datePublished:datetime('2012-04-27T14:25:35Z'), internalDocId:2353565, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Enters Definitive Agreement to Acquire EUSA Pharma"}}, {uri:"https://1145.am/db/848145/wwwbusinesswirecom_news_home_20220222006242_en_Moderna-and-Thermo-Fisher-Scientific-Announce-Long-Term-Strategic-Collaboration", properties:{datePublished:datetime('2022-02-23T13:00:00Z'), internalDocId:848145, deletedRedundantSameAsAt:1, sourceOrganization:"Business Wire", headline:"Moderna and Thermo Fisher Scientific Announce Long-Term Strategic Collaboration"}}, {uri:"https://1145.am/db/928077/apnewscom_press-release_Accesswire_covid-business-health-australia-melbourne-8aa2bb2fcf051dbd0f91d40cf93ee811", properties:{datePublished:datetime('2022-03-23T23:36:36Z'), internalDocId:928077, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Moderna Finalizes Strategic Partnership with Australian Government"}}, {uri:"https://1145.am/db/1020277/apnewscom_press-release_Accesswire_covid-business-health-canada-pandemics-d04450cc7b4e8c88ecf5e9c56a7e231c", properties:{datePublished:datetime('2022-04-29T14:11:38Z'), internalDocId:1020277, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Moderna Finalizes Plan for Long-Term Strategic Partnership with The Government of Canada"}}, {uri:"https://1145.am/db/1414120/apnewscom_press-release_accesswire_technology-health-cancer-clinical-trials-melanoma-6fff0620621ff0af61560d0e88548877", properties:{datePublished:datetime('2022-10-12T11:16:57Z'), internalDocId:1414120, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Merck and Moderna Announce Exercise of Option by Merck for Joint Development and Commercialization of Investigational Personalized Cancer Vaccine"}}, {uri:"https://1145.am/db/1661887/wwwbusinesswirecom_news_home_20230203005108_en_Personalis-and-Moderna-Sign-New-Agreement-to-Leverage-NeXT-Platform_E2_84_A2-in-Personalized-mRNA-Cancer-Vaccine-Clinical-Trials", properties:{datePublished:datetime('2023-02-03T13:45:00Z'), internalDocId:1661887, deletedRedundantSameAsAt:1, sourceOrganization:"Business Wire", headline:"Personalis and Moderna Sign New Agreement to Leverage NeXT Platform in Personalized mRNA Cancer Vaccine Clinical Trials"}}, {uri:"https://1145.am/db/3215326/wwwprnewswirecom_news-releases_ginkgo-bioworks-provides-support-on-process-optimization-to-moderna-for-covid-19-response-301040876html", properties:{datePublished:datetime('2020-04-15T13:00:00Z'), internalDocId:3215326, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-14T00:23:41Z'), sourceOrganization:"PR Newswire", headline:"Ginkgo Bioworks Provides Support on Process Optimization to Moderna for COVID-19 Response"}}, {uri:"https://1145.am/db/2544785/wwwfiercepharmacom_pharma_moderna-taps-national-resilience-s-new-canadian-manufacturing-site-for-covid-19-vaccine", properties:{datePublished:datetime('2021-09-08T15:06:02Z'), internalDocId:2544785, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Moderna taps National Resilience's new Canadian manufacturing site for COVID-19 vaccine production duties"}}, {uri:"https://1145.am/db/3739976/seekingalphacom_news_3923820-moderna-in-pact-for-us-vaccine-contract-targeting-ebola", properties:{datePublished:datetime('2023-01-11T17:07:54Z'), internalDocId:3739976, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T13:45:57Z'), sourceOrganization:"Seeking Alpha", headline:"Moderna in pact for U.S. vaccine contract targeting Ebola (NASDAQ:MRNA)"}}, {uri:"https://1145.am/db/3731989/seekingalphacom_news_4010507-moderna-pact-immatics-cancer-drugs", properties:{datePublished:datetime('2023-09-11T11:24:59Z'), internalDocId:3731989, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T13:18:37Z'), sourceOrganization:"Seeking Alpha", headline:"Moderna in pact with Immatics for cancer drugs (NASDAQ:MRNA)"}}, {uri:"https://1145.am/db/3659594/seekingalphacom_news_4036078-jazz-pharma-enters-collaboration-to-develop-neurological-drugs", properties:{datePublished:datetime('2023-11-14T10:40:42Z'), internalDocId:3659594, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T09:04:26Z'), sourceOrganization:"Seeking Alpha", headline:"Jazz Pharma enters collaboration to develop neurological drugs (NASDAQ:JAZZ)"}}, {uri:"https://1145.am/db/2576103/wwwfiercepharmacom_pharma_jazz-pharmaceuticals-and-gentium-s-p-a-announce-agreement-for-jazz-pharmaceuticals-to", properties:{datePublished:datetime('2013-12-20T13:25:01Z'), internalDocId:2576103, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz Pharmaceuticals And Gentium S.p.A. Announce Agreement For Jazz Pharmaceuticals To Acquire Gentium For $57.00 Per Share"}}, {uri:"https://1145.am/db/2345818/wwwfiercebiotechcom_financials_gentium-shareholders-cry-foul-on-1b-jazz-deal", properties:{datePublished:datetime('2014-01-16T16:05:43Z'), internalDocId:2345818, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Gentium shareholders cry foul on $1B Jazz deal"}}, {uri:"https://1145.am/db/4759477/wwwprnewswirecom_news-releases_oxford-properties-completes-us91-million-sale-of-newly-constructed-140-000-square-foot-boston-gmp-facility-to-pioneering-biotechnology-firm-moderna-301837254html", properties:{datePublished:datetime('2023-05-30T15:00:00Z'), internalDocId:4759477, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-10-30T02:17:39Z'), sourceOrganization:"PR Newswire", headline:"Oxford Properties Completes US$91 Million Sale of Newly Constructed, 140,000 Square Foot Boston GMP Facility to Pioneering Biotechnology Firm Moderna"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{uri:"https://1145.am/db/4815495/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-completes-us-divestiture-of-sunosi-solriamfetol-to-axsome-therapeutics-301542221html", properties:{datePublished:datetime('2022-05-09T11:00:00Z'), internalDocId:4815495, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T19:41:01Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Completes U.S. Divestiture of Sunosi (solriamfetol) to Axsome Therapeutics"}}, {uri:"https://1145.am/db/4858126/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-significant-new-investment-in-uk-manufacturing-301510400html", properties:{datePublished:datetime('2022-03-25T07:00:00Z'), internalDocId:4858126, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T22:26:12Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Significant New Investment in UK Manufacturing"}}, {uri:"https://1145.am/db/4819310/wwwprnewswirecom_news-releases_moderna-and-carisma-establish-collaboration-to-develop-in-vivo-engineered-chimeric-antigen-receptor-monocytes-car-m-for-oncology-301456651html", properties:{datePublished:datetime('2022-01-10T11:30:00Z'), internalDocId:4819310, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T19:54:24Z'), sourceOrganization:"PR Newswire", headline:"Moderna and Carisma Establish Collaboration to Develop in vivo Engineered Chimeric Antigen Receptor Monocytes (CAR-M) for Oncology"}}, {uri:"https://1145.am/db/4845820/wwwprnewswirecom_news-releases_umass-chan-medical-school-announces-research-collaboration-with-moderna-to-examine-impact-of-cytomegalovirus-cmv-in-young-children-301507080html", properties:{datePublished:datetime('2022-03-22T14:00:00Z'), internalDocId:4845820, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T21:32:21Z'), sourceOrganization:"PR Newswire", headline:"UMass Chan Medical School announces research collaboration with Moderna to examine impact of Cytomegalovirus (CMV) in young children"}}, {uri:"https://1145.am/db/4808151/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-and-sumitomo-pharma-announce-exclusive-license-agreement-to-develop-and-commercialize-dsp-0187-a-potent-highly-selective-oral-orexin-2-receptor-agonist-301537690html", properties:{datePublished:datetime('2022-05-04T20:05:00Z'), internalDocId:4808151, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T19:17:24Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals and Sumitomo Pharma Announce Exclusive License Agreement to Develop and Commercialize DSP-0187, a Potent, Highly Selective Oral Orexin-2 Receptor Agonist"}}, {uri:"https://1145.am/db/2316828/wwwfiercebiotechcom_biotech_press-release-interim-phase-2-data-for-exelixis_C3_A2_E2_82_AC_E2_84_A2-xl880-show-anti-tumor-activity-papillary", properties:{datePublished:datetime('2007-10-25T19:23:33Z'), internalDocId:2316828, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"PRESS RELEASE: INTERIM PHASE 2 DATA FOR EXELIXIS XL880 SHOW ANTI-TUMOR ACTIVITY IN PAPILLARY RENAL CELL CANCER"}}, {uri:"https://1145.am/db/2316829/wwwfiercebiotechcom_biotech_press-release-exelixis-reports-xl647-clinical-data-at-aacr-nci-eortc-conference", properties:{datePublished:datetime('2007-10-25T19:27:01Z'), internalDocId:2316829, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"PRESS RELEASE: EXELIXIS REPORTS XL647 CLINICAL DATA AT AACR-NCI-EORTC CONFERENCE"}}, {uri:"https://1145.am/db/2310010/wwwfiercebiotechcom_biotech_exelixis-initiates-phase-3-trial-of-xl184-medullary-thyroid-cancer", properties:{datePublished:datetime('2008-07-23T16:12:23Z'), internalDocId:2310010, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Initiates Phase 3 Trial of XL184 in Medullary Thyroid Cancer"}}, {uri:"https://1145.am/db/2366752/wwwfiercebiotechcom_biotech_exelixis-xl184-granted-orphan-drug-designation-and-assigned-generic-name-cabozantinib", properties:{datePublished:datetime('2011-01-10T11:26:20Z'), internalDocId:2366752, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis' XL184 Granted Orphan Drug Designation and Assigned the Generic Name Cabozantinib"}}, {uri:"https://1145.am/db/2347610/wwwfiercebiotechcom_biotech_cabozantinib-xl184-phase-2-data-demonstrate-encouraging-clinical-activity-patients", properties:{datePublished:datetime('2011-02-18T13:42:24Z'), internalDocId:2347610, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Cabozantinib (XL184) Phase 2 Data Demonstrate Encouraging Clinical Activity in Patients with Castration-Resistant Prostate Cance"}}, {uri:"https://1145.am/db/2360947/wwwfiercebiotechcom_biotech_exelixis-reports-positive-preliminary-phase-2-cabozantinib-data-patients-hepatocellular", properties:{datePublished:datetime('2012-01-23T17:39:13Z'), internalDocId:2360947, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Reports Positive Preliminary Phase 2 Cabozantinib Data in Patients with Hepatocellular Carcinoma"}}, {uri:"https://1145.am/db/2364863/wwwfiercebiotechcom_biotech_cabozantinib-shows-encouraging-activity-heavily-pretreated-patients-advanced-renal-cell", properties:{datePublished:datetime('2012-02-03T15:53:31Z'), internalDocId:2364863, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Cabozantinib Shows Encouraging Activity in Heavily Pretreated Patients With Advanced Renal Cell Carcinoma"}}, {uri:"https://1145.am/db/2578118/wwwfiercepharmacom_pharma_jazz-pharmaceuticals-announces-issuance-of-new-formulation-patent-for-xyrem_C2_AE", properties:{datePublished:datetime('2012-09-11T16:33:40Z'), internalDocId:2578118, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz Pharmaceuticals Announces Issuance of New Formulation Patent for Xyrem"}}, {uri:"https://1145.am/db/2353319/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-begins-clinical-trial-of-intravenously-administered-erwinaze_C2_AE-patients", properties:{datePublished:datetime('2012-12-04T05:00:05Z'), internalDocId:2353319, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Begins Clinical Trial of Intravenously Administered Erwinaze In Patients with Acute Lymphoblastic Leukemia"}}, {uri:"https://1145.am/db/2354315/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-announces-issuance-of-additional-xyrem_C2_AE-patent", properties:{datePublished:datetime('2012-12-05T05:00:22Z'), internalDocId:2354315, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Announces Issuance of Additional Xyrem Patent"}}, {uri:"https://1145.am/db/2351946/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-initiates-rolling-nda-submission-for-defibrotide-for-treatment-of", properties:{datePublished:datetime('2014-12-12T16:30:34Z'), internalDocId:2351946, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Initiates Rolling NDA Submission For Defibrotide For The Treatment Of Severe Hepatic Veno-Occlusive Disease"}}, {uri:"https://1145.am/db/2368452/wwwfiercebiotechcom_biotech_exelixis-announces-positive-top-line-results-from-meteor-phase-3-pivotal-trial-of", properties:{datePublished:datetime('2015-07-20T12:27:55Z'), internalDocId:2368452, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Announces Positive Top-Line Results from METEOR, the Phase 3 Pivotal Trial of Cabozantinib versus Everolimus in Patients with Metastatic Renal Cell Carcinoma"}}, {uri:"https://1145.am/db/2308891/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-and-ucb-announce-positive-phase-iii-results-for-sodium-oxybate-jzp-6", properties:{datePublished:datetime('2008-11-20T22:20:39Z'), internalDocId:2308891, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals and UCB Announce Positive Phase III Results for Sodium Oxybate (JZP-6) in Fibromyalgia"}}, {uri:"https://1145.am/db/2370702/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-announces-u-s-fda-acceptance-for-filing-priority-review-of-nda-for", properties:{datePublished:datetime('2015-09-30T15:27:07Z'), internalDocId:2370702, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Announces U.S. FDA Acceptance for Filing with Priority Review of NDA for Defibrotide for Hepatic Veno-Occlusive Disease"}}, {uri:"https://1145.am/db/2368147/wwwfiercebiotechcom_biotech_exelixis-announces-european-commission-approval-of-cotellic_E2_84_A2-cobimetinib-for-use", properties:{datePublished:datetime('2015-11-25T16:15:21Z'), internalDocId:2368147, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Announces European Commission Approval of COTELLIC (Cobimetinib) for Use in Combination with Vemurafenib in Advanced BRAF V600 Mutation-Positive Melanoma"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{uri:"https://1145.am/db/2344820/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-announces-acquisition-from-aerial-biopharma-of-rights-to-a-late-stage", properties:{datePublished:datetime('2014-01-14T15:09:31Z'), internalDocId:2344820, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Announces Acquisition From Aerial Biopharma Of Rights To A Late Stage Investigational Compound For Excessive Daytime Sleepiness"}}, {uri:"https://1145.am/db/2348785/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-announces-agreement-to-acquire-rights-to-defibrotide-americas-from", properties:{datePublished:datetime('2014-07-02T12:45:48Z'), internalDocId:2348785, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Announces Agreement To Acquire Rights To Defibrotide In The Americas From Sigma-Tau Pharmaceuticals, Inc."}}, {uri:"https://1145.am/db/2314334/wwwfiercebiotechcom_biotech_bristol-myers-squibb-and-exelixis-enter-global-collaboration-on-two-novel-cancer-programs", properties:{datePublished:datetime('2008-12-12T12:55:10Z'), internalDocId:2314334, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Bristol-Myers Squibb and Exelixis Enter Global Collaboration on Two Novel Cancer Programs"}}, {uri:"https://1145.am/db/2370370/wwwfiercebiotechcom_biotech_exelixis-and-ipsen-enter-into-exclusive-licensing-agreement-to-commercialize-and-develop", properties:{datePublished:datetime('2016-03-01T13:08:22Z'), internalDocId:2370370, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis and Ipsen Enter into Exclusive Licensing Agreement to Commercialize and Develop Novel Cancer Therapy Cabozantinib in Regions Outside the United States, Canada and Japan"}}, {uri:"https://1145.am/db/3869856/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-first-patient-enrolled-in-phase-2-clinical-trial-evaluating-defibrotide-for-the-prevention-of-acute-graft-versus-host-disease-300603339html", properties:{datePublished:datetime('2018-02-23T13:30:00Z'), internalDocId:3869856, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T23:18:21Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating Defibrotide for the Prevention of Acute Graft-versus-Host Disease"}}, {uri:"https://1145.am/db/3763144/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-submits-supplemental-new-drug-application-for-xyrem-sodium-oxybate-to-treat-cataplexy-and-excessive-daytime-sleepiness-in-pediatric-narcolepsy-patients-300640005html", properties:{datePublished:datetime('2018-05-01T12:30:00Z'), internalDocId:3763144, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T16:51:57Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Submits Supplemental New Drug Application for Xyrem (sodium oxybate) to Treat Cataplexy and Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients"}}, {uri:"https://1145.am/db/3934272/wwwprnewswirecom_news-releases_vyxeos-receives-positive-chmp-opinion-for-treatment-of-certain-types-of-high-risk-acute-myeloid-leukaemia-300674611html", properties:{datePublished:datetime('2018-06-29T12:15:00Z'), internalDocId:3934272, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-19T03:13:34Z'), sourceOrganization:"PR Newswire", headline:"Vyxeos Receives Positive CHMP Opinion for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia"}}, {uri:"https://1145.am/db/2575279/wwwfiercepharmacom_m-a_jazz-pharmaceuticals-announces-another-deal", properties:{datePublished:datetime('2012-04-26T22:06:34Z'), internalDocId:2575279, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz Pharmaceuticals announces another deal"}}, {uri:"https://1145.am/db/4861500/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-agreement-to-divest-sunosi-solriamfetol-to-axsome-therapeutics-301511396html", properties:{datePublished:datetime('2022-03-28T10:00:00Z'), internalDocId:4861500, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T22:42:14Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Agreement to Divest Sunosi (solriamfetol) to Axsome Therapeutics"}}, {uri:"https://1145.am/db/4815678/wwwprnewswirecom_news-releases_axsome-therapeutics-completes-us-acquisition-of-sunosi-solriamfetol-for-excessive-daytime-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea-301542239html", properties:{datePublished:datetime('2022-05-09T11:48:00Z'), internalDocId:4815678, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T19:41:33Z'), sourceOrganization:"PR Newswire", headline:"Axsome Therapeutics Completes U.S. Acquisition of Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea"}}, {uri:"https://1145.am/db/3914041/wwwprnewswirecom_news-releases_journal-of-clinical-oncology-publishes-pivotal-phase-3-data-for-jazz-pharmaceuticals-vyxeos-daunorubicin-and-cytarabine-liposome-for-injection-300684026html", properties:{datePublished:datetime('2018-07-19T20:45:00Z'), internalDocId:3914041, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-19T02:00:03Z'), sourceOrganization:"PR Newswire", headline:"Journal of Clinical Oncology publishes pivotal Phase 3 data for Jazz Pharmaceuticals' Vyxeos (daunorubicin and cytarabine) Liposome for Injection"}}, {uri:"https://1145.am/db/3914042/wwwprnewswirecom_news-releases_journal-of-clinical-oncology-publishes-pivotal-phase-3-data-for-jazz-pharmaceuticals-vyxeos-688657681html", properties:{datePublished:datetime('2018-07-19T20:51:00Z'), internalDocId:3914042, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-19T02:00:03Z'), sourceOrganization:"PR Newswire", headline:"Journal of Clinical Oncology publishes pivotal Phase 3 data for Jazz Pharmaceuticals' Vyxeos (daunorubicin and cytarabine) Liposome for Injection"}}, {uri:"https://1145.am/db/3776206/wwwprnewswirecom_news-releases_cms-grants-new-technology-add-on-payment-to-vyxeos-daunorubicin-and-cytarabine-liposome-for-injection-300691714html", properties:{datePublished:datetime('2018-08-03T12:00:00Z'), internalDocId:3776206, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T17:42:06Z'), sourceOrganization:"PR Newswire", headline:"CMS Grants New Technology Add-On Payment to Vyxeos (daunorubicin and cytarabine) Liposome for Injection"}}, {uri:"https://1145.am/db/3870222/wwwprnewswirecom_news-releases_vyxeos-receives-marketing-authorisation-in-the-european-union-for-treatment-of-certain-types-of-high-risk-acute-myeloid-leukaemia-300702499html", properties:{datePublished:datetime('2018-08-27T06:00:00Z'), internalDocId:3870222, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T23:19:55Z'), sourceOrganization:"PR Newswire", headline:"Vyxeos Receives Marketing Authorisation in the European Union for Treatment of Certain Types of High-Risk Acute Myeloid Leukaemia"}}, {uri:"https://1145.am/db/2321635/wwwfiercebiotechcom_biotech_after-holiday-weekend-rumors-jazz-confirms-1-5b-buyout-tiny-celator", properties:{datePublished:datetime('2016-05-31T08:45:35Z'), internalDocId:2321635, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"After holiday weekend rumors, Jazz confirms $1.5B buyout of tiny Celator"}}, {uri:"https://1145.am/db/3001653/wwwcityamcom_ireland-based-jazz-pharmaceuticals-seals-the-deal-with-celator-for-15bn", properties:{datePublished:datetime('2016-05-31T13:14:00Z'), internalDocId:3001653, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2023-12-20T03:59:16Z'), sourceOrganization:"CityAM", headline:"Ireland-based Jazz Pharmaceuticals seals the deal with Celator for $1.5bn tie-up"}}, {uri:"https://1145.am/db/3436539/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-us-fda-approval-of-sunosi-solriamfetol-for-excessive-daytime-sleepiness-associated-with-narcolepsy-or-obstructive-sleep-apnea-300816081html", properties:{datePublished:datetime('2019-03-20T22:53:00Z'), internalDocId:3436539, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-17T16:10:57Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces U.S. FDA Approval of Sunosi (solriamfetol) for Excessive Daytime Sleepiness Associated with Narcolepsy or Obstructive Sleep Apnea"}}, {uri:"https://1145.am/db/3483970/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-positive-top-line-results-from-phase-3-study-of-jzp-258-in-adult-narcolepsy-patients-with-cataplexy-and-excessive-daytime-sleepiness-300819008html", properties:{datePublished:datetime('2019-03-26T20:13:00Z'), internalDocId:3483970, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-17T17:30:15Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of JZP-258 in Adult Narcolepsy Patients with Cataplexy and Excessive Daytime Sleepiness"}}, {uri:"https://1145.am/db/3919064/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-fda-approval-of-xyrem-sodium-oxybate-for-the-treatment-of-cataplexy-or-excessive-daytime-sleepiness-in-pediatric-narcolepsy-patients-300739288html", properties:{datePublished:datetime('2018-10-29T12:00:00Z'), internalDocId:3919064, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-19T02:17:41Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces FDA Approval of Xyrem (sodium oxybate) for the Treatment of Cataplexy or Excessive Daytime Sleepiness in Pediatric Narcolepsy Patients"}}, {uri:"https://1145.am/db/3557631/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-receives-positive-chmp-opinion-for-solriamfetol-to-improve-wakefulness-and-reduce-excessive-daytime-sleepiness-in-adults-with-narcolepsy-or-obstructive-sleep-apnea-300959111html", properties:{datePublished:datetime('2019-11-15T11:45:00Z'), internalDocId:3557631, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-17T19:18:47Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Receives Positive CHMP Opinion for Solriamfetol to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{uri:"https://1145.am/db/3234395/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-receives-eu-marketing-authorisation-for-sunosi-solriamfetol-for-excessive-daytime-sleepiness-in-adults-with-narcolepsy-or-obstructive-sleep-apnea-300989638html", properties:{datePublished:datetime('2020-01-20T15:35:00Z'), internalDocId:3234395, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-14T00:51:29Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Receives EU Marketing Authorisation for Sunosi (solriamfetol) for Excessive Daytime Sleepiness in Adults with Narcolepsy or Obstructive Sleep Apnea"}}, {uri:"https://1145.am/db/3248290/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-submits-new-drug-application-for-jzp-258-for-cataplexy-and-excessive-daytime-sleepiness-associated-with-narcolepsy-300991187html", properties:{datePublished:datetime('2020-01-22T13:00:00Z'), internalDocId:3248290, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-14T01:11:26Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Submits New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy"}}, {uri:"https://1145.am/db/3808173/wwwprnewswirecom_news-releases_national-institute-for-health-and-care-excellence-nice-recommends-jazz-pharmaceuticals-vyxeos-daunorubicin-and-cytarabine-for-adults-with-specific-types-of-secondary-acute-myeloid-leukaemia-aml-300746025html", properties:{datePublished:datetime('2018-11-08T00:05:00Z'), internalDocId:3808173, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T19:36:10Z'), sourceOrganization:"PR Newswire", headline:"National Institute for Health and Care Excellence (NICE) Recommends Jazz Pharmaceuticals' Vyxeos (Daunorubicin and Cytarabine) for Adults with Specific Types of Secondary Acute Myeloid Leukaemia (AML)"}}, {uri:"https://1145.am/db/3818868/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-submits-marketing-authorization-application-to-european-medicines-agency-for-solriamfetol-as-a-treatment-to-improve-wakefulness-and-reduce-excessive-daytime-sleepiness-in-adult-patients-with-narcolepsy-or-obst-300747377html", properties:{datePublished:datetime('2018-11-09T07:00:00Z'), internalDocId:3818868, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T20:12:53Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Submits Marketing Authorization Application to European Medicines Agency for Solriamfetol as a Treatment to Improve Wakefulness and Reduce Excessive Daytime Sleepiness in Adult Patients with Narcolepsy or Obstructive Sleep Apnea"}}, {uri:"https://1145.am/db/3347551/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-fda-acceptance-of-new-drug-application-for-jzp-258-for-cataplexy-and-excessive-daytime-sleepiness-associated-with-narcolepsy-301029906html", properties:{datePublished:datetime('2020-03-25T20:05:00Z'), internalDocId:3347551, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-14T04:22:53Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces FDA Acceptance of New Drug Application for JZP-258 for Cataplexy and Excessive Daytime Sleepiness Associated with Narcolepsy"}}, {uri:"https://1145.am/db/2295041/wwwfiercebiotechcom_biotech_moderna-gains-barda-zika-vax-funding-closes-474m-funding-round", properties:{datePublished:datetime('2016-09-07T12:05:00Z'), internalDocId:2295041, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Moderna gains BARDA Zika vax funding, closes $474M funding round"}}, {uri:"https://1145.am/db/2552053/wwwfiercepharmacom_vaccines_moderna-prices-covid-19-vaccine-at-32-to-37-for-small-purchasers", properties:{datePublished:datetime('2020-08-05T15:20:00Z'), internalDocId:2552053, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Moderna prices coronavirus shot at up to $37 per dose for small deals. What will big customers get?"}}, {uri:"https://1145.am/db/3149417/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-positive-top-line-results-from-phase-3-study-of-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-in-adult-patients-with-idiopathic-hypersomnia-301148512html", properties:{datePublished:datetime('2020-10-08T11:30:00Z'), internalDocId:3149417, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-13T22:52:46Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Positive Top-line Results from Phase 3 Study of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution in Adult Patients with Idiopathic Hypersomnia"}}, {uri:"https://1145.am/db/3178351/wwwprnewswirecom_news-releases_new-data-for-zepzelca-lurbinectedin-to-be-presented-at-iaslc-2020-north-america-conference-on-lung-cancer-301152493html", properties:{datePublished:datetime('2020-10-14T20:05:00Z'), internalDocId:3178351, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-13T23:27:10Z'), sourceOrganization:"PR Newswire", headline:"New Data for Zepzelca (lurbinectedin) to be Presented at IASLC 2020 North America Conference on Lung Cancer"}}, {uri:"https://1145.am/db/3199601/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-sleep-publication-of-phase-3-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-study-in-cataplexy-or-excessive-daytime-sleepiness-in-patients-with-narcolepsy-301155706html", properties:{datePublished:datetime('2020-10-20T11:30:00Z'), internalDocId:3199601, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-13T23:59:32Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces SLEEP Publication of Phase 3 Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution Study in Cataplexy or Excessive Daytime Sleepiness in Patients with Narcolepsy"}}, {uri:"https://1145.am/db/3058456/wwwcityamcom_moderna-seeks-green-light-from-us-and-eu-for-covid-19-vaccine", properties:{datePublished:datetime('2020-11-30T15:50:24Z'), internalDocId:3058456, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2023-12-20T05:37:42Z'), sourceOrganization:"CityAM", headline:"Moderna seeks green light from US and EU for Covid-19 vaccine"}}, {uri:"https://1145.am/db/3918978/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-first-patient-enrolled-in-phase-3-clinical-trial-evaluating-jzp-258-for-the-treatment-of-idiopathic-hypersomnia-300757548html", properties:{datePublished:datetime('2018-11-29T13:00:00Z'), internalDocId:3918978, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-19T02:17:19Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating JZP-258 for the Treatment of Idiopathic Hypersomnia"}}, {uri:"https://1145.am/db/5064686/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-ceo-succession-plan-302332980html", properties:{datePublished:datetime('2024-12-16T21:05:00Z'), internalDocId:5064686, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-12-17T05:10:27Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces CEO Succession Plan"}}, {uri:"https://1145.am/db/4121340/seekingalphacom_news_4083644-moderna-stock-gains-next-gen-covid-shot-data", properties:{datePublished:datetime('2024-03-26T12:15:09Z'), internalDocId:4121340, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-03-27T08:22:09Z'), sourceOrganization:"Seeking Alpha", headline:"Moderna stock gains on next-gen COVID shot data (NASDAQ:MRNA)"}}, {uri:"https://1145.am/db/4853858/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-first-patient-enrolled-in-emerge-201-phase-2-basket-trial-evaluating-zepzelca-lurbinectedin-monotherapy-in-patients-with-select-advanced-or-metastatic-solid-tumors-301509864html", properties:{datePublished:datetime('2022-03-24T11:30:00Z'), internalDocId:4853858, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T22:02:29Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces First Patient Enrolled in EMERGE-201 Phase 2 Basket Trial Evaluating Zepzelca (lurbinectedin) Monotherapy in Patients with Select Advanced or Metastatic Solid Tumors"}}, {uri:"https://1145.am/db/4756667/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-provides-update-on-phase-2-trial-of-investigational-jzp150-in-adult-patients-with-post-traumatic-stress-disorder-302021299html", properties:{datePublished:datetime('2023-12-21T21:05:00Z'), internalDocId:4756667, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-10-30T02:05:57Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Provides Update on Phase 2 Trial of Investigational JZP150 in Adult Patients with Post-Traumatic Stress Disorder"}}, {uri:"https://1145.am/db/4935578/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-first-patient-enrolled-in-phase-2-clinical-trial-evaluating-jzp150-for-once-daily-treatment-of-adults-with-post-traumatic-stress-disorder-301451838html", properties:{datePublished:datetime('2021-12-30T12:45:00Z'), internalDocId:4935578, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-05T09:39:07Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2 Clinical Trial Evaluating JZP150 for Once-Daily Treatment of Adults with Post-Traumatic Stress Disorder"}}, {uri:"https://1145.am/db/4806958/wwwprnewswirecom_news-releases_us-fda-grants-orphan-drug-exclusivity-ode-for-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-for-idiopathic-hypersomnia-in-adults-301452921html", properties:{datePublished:datetime('2022-01-03T21:10:00Z'), internalDocId:4806958, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T19:13:23Z'), sourceOrganization:"PR Newswire", headline:"U.S. FDA Grants Orphan Drug Exclusivity (ODE) for Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia in Adults"}}, {uri:"https://1145.am/db/4811317/wwwprnewswirecom_news-releases_lancet-neurology-publishes-positive-pivotal-phase-3-data-of-xywav-calcium-magnesium-potassium-and-sodium-oxybates-oral-solution-for-idiopathic-hypersomnia-301454171html", properties:{datePublished:datetime('2022-01-05T12:45:00Z'), internalDocId:4811317, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T19:27:24Z'), sourceOrganization:"PR Newswire", headline:"Lancet Neurology Publishes Positive, Pivotal Phase 3 Data of Xywav (calcium, magnesium, potassium, and sodium oxybates) Oral Solution for Idiopathic Hypersomnia"}}, {uri:"https://1145.am/db/1477814/apnewscom_press-release_accesswire_health-business-covid-immunizations-72966aa73cb24c7f2cdd7cf92c62ee6c", properties:{datePublished:datetime('2022-11-04T21:01:55Z'), internalDocId:1477814, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Moderna Receives Health Canada Authorization for Second Omicron-Targeting Bivalent Booster"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{uri:"https://1145.am/db/3751907/seekingalphacom_news_3985407-moderna-stock-gains-amid-marketing-submissions-rsv-shot", properties:{datePublished:datetime('2023-07-05T11:31:28Z'), internalDocId:3751907, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T14:26:51Z'), sourceOrganization:"Seeking Alpha", headline:"Moderna stock gains amid marketing submissions for RSV shot"}}, {uri:"https://1145.am/db/4898222/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-to-present-from-expanding-neuroscience-portfolio-epidiolex-cannabidiol-oral-solution-data-at-the-2021-american-epilepsy-society-annual-meeting-301434871html", properties:{datePublished:datetime('2021-12-01T12:45:00Z'), internalDocId:4898222, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-05T07:16:22Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals to Present from Expanding Neuroscience Portfolio Epidiolex (cannabidiol) Oral Solution Data at the 2021 American Epilepsy Society Annual Meeting"}}, {uri:"https://1145.am/db/2301130/wwwfiercebiotechcom_biotech_moderna-raises-500m-to-move-mrna-drugs-deeper-into-human-tests", properties:{datePublished:datetime('2018-02-02T09:17:02Z'), internalDocId:2301130, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Moderna raises $500M to move mRNA drugs deeper into human tests"}}, {uri:"https://1145.am/db/4321683/seekingalphacom_news_4115478-moderna-marks-trial-win-next-gen-covid-shot", properties:{datePublished:datetime('2024-06-13T11:26:13Z'), internalDocId:4321683, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-06-17T12:02:25Z'), sourceOrganization:"Seeking Alpha", headline:"Moderna marks trial win for next-gen COVID shot (NASDAQ:MRNA)"}}, {uri:"https://1145.am/db/4649015/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-presents-updated-phase-2-data-for-zanidatamab-demonstrating-increased-mpfs-in-her2-positive-metastatic-gastroesophageal-adenocarcinoma-at-esmo-2024-302248513html", properties:{datePublished:datetime('2024-09-16T11:30:00Z'), internalDocId:4649015, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-10-29T18:09:12Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Presents Updated Phase 2 Data for Zanidatamab Demonstrating Increased mPFS in HER2-Positive Metastatic Gastroesophageal Adenocarcinoma at ESMO 2024"}}, {uri:"https://1145.am/db/4994339/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-us-fda-approval-of-ziihera-zanidatamab-hrii-for-the-treatment-of-adults-with-previously-treated-unresectable-or-metastatic-her2-positive-ihc-3-biliary-tract-cancer-btc-302312216html", properties:{datePublished:datetime('2024-11-21T00:19:00Z'), internalDocId:4994339, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-21T05:12:41Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract Cancer (BTC)"}}, {uri:"https://1145.am/db/5003388/wwwglobenewswirecom_news-release_2024_11_25_2986473_0_en_US-FDA-Grants-Approval-For-Zanidatamab-Ziihera-Bispecific-Antibody-For-Biliary-Tract-Cancerhtml", properties:{datePublished:datetime('2024-11-25T10:47:49Z'), internalDocId:5003388, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-25T20:45:31Z'), sourceOrganization:"GlobeNewswire", headline:"US FDA Grants Approval For Zanidatamab Ziihera Bispecific Antibody For Biliary Tract Cancer"}}, {uri:"https://1145.am/db/2310180/wwwfiercebiotechcom_biotech_also-noted-renovis-drops-ms-compound-lorus-gets-rolling-nda-biotechs-lament-grants-rule-and", properties:{datePublished:datetime('2005-06-13T00:00:50Z'), internalDocId:2310180, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"ALSO NOTED: Renovis drops MS compound, Lorus gets rolling NDA, Biotechs lament grants rule, and much more..."}}, {uri:"https://1145.am/db/2314213/wwwfiercebiotechcom_biotech_press-release-exelixis-reinitiates-clinical-development-of-xl999", properties:{datePublished:datetime('2007-04-24T16:33:00Z'), internalDocId:2314213, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Press Release: Exelixis Reinitiates Clinical Development of XL999"}}, {uri:"https://1145.am/db/2313620/wwwfiercebiotechcom_biotech_press-release-exelixis-diabetic-nephropathy-drug-trial-fails-goal", properties:{datePublished:datetime('2007-10-16T13:44:39Z'), internalDocId:2313620, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"PRESS RELEASE: Exelixis Diabetic Nephropathy Drug Trial Fails Goal"}}, {uri:"https://1145.am/db/2316834/wwwfiercebiotechcom_biotech_also-noted-antigenics-releases-positive-cancer-results-novabay-raises-24m-bionovo-wraps", properties:{datePublished:datetime('2007-10-26T10:59:50Z'), internalDocId:2316834, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"ALSO NOTED: Antigenics releases positive cancer results, NovaBay raises $24M, Bionovo wraps stock offering, and much more..."}}, {uri:"https://1145.am/db/2320107/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-inc-announces-third-quarter-2007-financial-results", properties:{datePublished:datetime('2007-11-06T22:18:45Z'), internalDocId:2320107, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals, Inc. Announces Third Quarter 2007 Financial Results"}}, {uri:"https://1145.am/db/2302235/wwwfiercebiotechcom_biotech_exelixis-reports-encouraging-phase-1-data-for-xl184-at-asco", properties:{datePublished:datetime('2008-06-01T21:20:58Z'), internalDocId:2302235, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Reports Encouraging Phase 1 Data for XL184 at ASCO"}}, {uri:"https://1145.am/db/2303323/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-announces-development-timeline-updates", properties:{datePublished:datetime('2008-06-12T15:11:31Z'), internalDocId:2303323, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Announces Development Timeline Updates"}}, {uri:"https://1145.am/db/2321005/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-inc-announces-final-patient-has-completed-phase-iii-clinical-trial-of", properties:{datePublished:datetime('2008-09-11T16:09:39Z'), internalDocId:2321005, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"JAZZ PHARMACEUTICALS, INC. ANNOUNCES FINAL PATIENT HAS COMPLETED PHASE III CLINICAL TRIAL OF SODIUM OXYBATE TO TREAT FIBROMYALGI"}}, {uri:"https://1145.am/db/2541506/wwwfiercepharmacom_pharma_jazz-pharma-cuts-67-jobs-on-sales-decline-king-painkiller-likely-to-get-fda-nod", properties:{datePublished:datetime('2008-11-14T13:58:09Z'), internalDocId:2541506, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz Pharma cuts 67 jobs on sales decline, King painkiller likely to get FDA nod,"}}, {uri:"https://1145.am/db/2304748/wwwfiercebiotechcom_biotech_exelixis-cuts-10-of-workforce", properties:{datePublished:datetime('2008-11-10T13:31:45Z'), internalDocId:2304748, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis cuts 10% of workforce"}}, {uri:"https://1145.am/db/2306698/wwwfiercebiotechcom_biotech_jazz-cuts-67-jobs", properties:{datePublished:datetime('2008-11-13T15:17:47Z'), internalDocId:2306698, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz cuts 67 jobs"}}, {uri:"https://1145.am/db/2306688/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-inc-cuts-67-jobs-q3-loss-grows-to-28-8m", properties:{datePublished:datetime('2008-11-13T15:03:13Z'), internalDocId:2306688, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals, Inc. Cuts 67 Jobs, Q3 Loss Grows to $28.8M"}}, {uri:"https://1145.am/db/2315413/wwwfiercebiotechcom_biotech_jazz-and-arpida-cut-costs-jobs", properties:{datePublished:datetime('2008-12-16T15:33:40Z'), internalDocId:2315413, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz and Arpida cut costs, jobs"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{uri:"https://1145.am/db/2315388/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-announces-reduction-force-to-reflect-streamlined-operations", properties:{datePublished:datetime('2008-12-16T14:39:31Z'), internalDocId:2315388, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Announces Reduction in Force to Reflect Streamlined Operations"}}, {uri:"https://1145.am/db/2321447/wwwfiercebiotechcom_biotech_exelixis-chops-270-jobs-restructuring", properties:{datePublished:datetime('2010-03-09T08:25:58Z'), internalDocId:2321447, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis chops 270 jobs in restructuring"}}, {uri:"https://1145.am/db/2321449/wwwfiercebiotechcom_biotech_exelixis-announces-restructuring", properties:{datePublished:datetime('2010-03-09T12:22:20Z'), internalDocId:2321449, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Announces Restructuring"}}, {uri:"https://1145.am/db/2346830/wwwfiercebiotechcom_biotech_exelixis-announces-may-11-webcast-of-first-quarter-2010-financial-results-conference-call", properties:{datePublished:datetime('2010-04-28T14:19:21Z'), internalDocId:2346830, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Announces May 11 Webcast of First Quarter 2010 Financial Results Conference Call"}}, {uri:"https://1145.am/db/2345582/wwwfiercebiotechcom_biotech_exelixis-announces-august-5-webcast-of-second-quarter-2010-financial-results-conference", properties:{datePublished:datetime('2010-07-29T11:01:20Z'), internalDocId:2345582, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Announces August 5 Webcast of Second Quarter 2010 Financial Results Conference Call"}}, {uri:"https://1145.am/db/2344104/wwwfiercebiotechcom_biotech_exelixis-announces-november-4-webcast-of-third-quarter-2010-financial-results-conference", properties:{datePublished:datetime('2010-10-26T12:22:59Z'), internalDocId:2344104, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Announces November 4 Webcast of Third Quarter 2010 Financial Results Conference Call"}}, {uri:"https://1145.am/db/2354448/wwwfiercebiotechcom_biotech_exelixis-reports-promising-interim-data-from-patients-ovarian-cancer-treated-xl184", properties:{datePublished:datetime('2010-11-18T16:27:42Z'), internalDocId:2354448, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Reports Promising Interim Data From Patients With Ovarian Cancer Treated With XL184"}}, {uri:"https://1145.am/db/2345499/wwwfiercebiotechcom_biotech_exelixis-announces-february-22-webcast-of-its-fourth-quarter-full-year-2010-financial", properties:{datePublished:datetime('2011-02-10T11:20:27Z'), internalDocId:2345499, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Announces February 22 Webcast of Its Fourth Quarter & Full Year 2010 Financial Results Conference Call"}}, {uri:"https://1145.am/db/2585215/wwwfiercepharmacom_pharma_exelixis-announces-february-22-webcast-of-its-fourth-quarter-full-year-2010-financial", properties:{datePublished:datetime('2011-02-10T11:20:09Z'), internalDocId:2585215, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Exelixis Announces February 22 Webcast of Its Fourth Quarter & Full Year 2010 Financial Results Conference Call"}}, {uri:"https://1145.am/db/2350391/wwwfiercebiotechcom_biotech_exelixis-cabozantinib-phase-2-data-demonstrate-encouraging-clinical-activity-patients", properties:{datePublished:datetime('2011-06-06T18:34:46Z'), internalDocId:2350391, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis' Cabozantinib Phase 2 Data Demonstrate Encouraging Clinical Activity in Patients with Metastatic Castration-Resistant P"}}, {uri:"https://1145.am/db/2597977/wwwfiercepharmacom_pharma_viiv-pulls-app-for-new-selzentry-indication-u-s-hikma-unit-aims-for-cmo-growth-on-drug", properties:{datePublished:datetime('2011-09-21T13:07:44Z'), internalDocId:2597977, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"ViiV pulls app for new Selzentry indication, U.S. Hikma unit aims for CMO growth on drug shortages,"}}, {uri:"https://1145.am/db/2357755/wwwfiercebiotechcom_biotech_exelixis-initiates-comet-1-pivotal-trial-focused-on-overall-survival-men-advanced-prostate", properties:{datePublished:datetime('2012-05-30T14:23:56Z'), internalDocId:2357755, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Initiates COMET-1 Pivotal Trial Focused on Overall Survival in Men With Advanced Prostate Cancer"}}, {uri:"https://1145.am/db/3933752/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-enters-into-agreement-with-tersera-therapeutics-llc-for-prialt-300674775html", properties:{datePublished:datetime('2018-06-29T20:05:00Z'), internalDocId:3933752, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-19T03:11:45Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Enters Into Agreement with TerSera Therapeutics LLC for Prialt"}}, {uri:"https://1145.am/db/2593627/wwwfiercepharmacom_pharma_jazz-pharmaceuticals-announces-second-quarter-2012-results", properties:{datePublished:datetime('2012-08-08T01:08:08Z'), internalDocId:2593627, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz Pharmaceuticals Announces Second Quarter 2012 Results"}}, {uri:"https://1145.am/db/2584928/wwwfiercepharmacom_pharma_fda-suspects-meningitis-risk-2-more-necc-drugs-novartis-clings-to-69-share-of-diovan-hct", properties:{datePublished:datetime('2012-10-16T15:42:19Z'), internalDocId:2584928, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"FDA suspects meningitis risk with 2 more NECC drugs, Novartis clings to 69% share of Diovan HCT sales,"}}, {uri:"https://1145.am/db/2343897/wwwfiercebiotechcom_biotech_medivir-splits-r-d-biomarin-launches-late-stage-study-of-pompe-drug", properties:{datePublished:datetime('2013-03-21T15:31:38Z'), internalDocId:2343897, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Medivir splits R&D, BioMarin launches late-stage study of Pompe drug,"}}, {uri:"https://1145.am/db/2351113/wwwfiercebiotechcom_biotech_exelixis-initiates-phase-3-clinical-trial-of-cabozantinib-patients-advanced-hepatocellular", properties:{datePublished:datetime('2013-09-10T14:59:49Z'), internalDocId:2351113, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Initiates Phase 3 Clinical Trial of Cabozantinib in Patients With Advanced Hepatocellular Carcinoma"}}, {uri:"https://1145.am/db/2350863/wwwfiercebiotechcom_biotech_exelixis-announces-positive-top-line-results-for-phase-3-pivotal-trial-of-cobimetinib", properties:{datePublished:datetime('2014-07-14T11:52:39Z'), internalDocId:2350863, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Announces Positive Top-Line Results for Phase 3 Pivotal Trial of Cobimetinib in Combination With Vemurafenib in Patients With BRAF V600 Mutation-Positive Advanced Melanoma"}}, {uri:"https://1145.am/db/2579294/wwwfiercepharmacom_pharma_exelixis-announces-results-from-comet-1-phase-3-pivotal-trial-of-cabozantinib-men-metastatic", properties:{datePublished:datetime('2014-09-02T15:20:42Z'), internalDocId:2579294, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Exelixis Announces Results from the COMET-1 Phase 3 Pivotal Trial of Cabozantinib in Men with Metastatic Castration-Resistant Prostate Cancer"}}, {uri:"https://1145.am/db/2561252/wwwfiercepharmacom_pharma-asia_jazz-pharmaceuticals-announces-first-patients-enrolled-phase-3-clinical-development", properties:{datePublished:datetime('2015-06-09T12:49:30Z'), internalDocId:2561252, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz Pharmaceuticals Announces First Patients Enrolled in Phase 3 Clinical Development Program Evaluating JZP-110 as a Potential Treatment of Excessive Daytime Sleepiness (EDS) Associated with Narcolepsy or with Obstructive Sleep Apnea (OSA)"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{uri:"https://1145.am/db/2310978/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-inc-announces-board-of-directors-and-management-changes", properties:{datePublished:datetime('2009-04-03T01:18:38Z'), internalDocId:2310978, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals, Inc. Announces Board of Directors and Management Changes"}}, {uri:"https://1145.am/db/2310994/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-announces-board-of-directors-and-management-changes-ceo-samuel-r-saks", properties:{datePublished:datetime('2009-04-03T14:42:23Z'), internalDocId:2310994, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Announces Board of Directors and Management Changes, CEO Samuel R. Saks Resigns"}}, {uri:"https://1145.am/db/2559729/wwwfiercepharmacom_vaccines_merck-ceo-frazier-touts-gardasil-sales-performance-vaccine-r-d-efforts", properties:{datePublished:datetime('2017-06-12T10:00:01Z'), internalDocId:2559729, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Merck CEO: Gardasil plus pipeline equals big things ahead for vaccines"}}, {uri:"https://1145.am/db/2301968/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-appoints-kathryn-falberg-as-chief-financial-officer", properties:{datePublished:datetime('2009-12-03T18:38:55Z'), internalDocId:2301968, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Appoints Kathryn Falberg as Chief Financial Officer"}}, {uri:"https://1145.am/db/3899582/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-full-year-and-fourth-quarter-2017-financial-results-300605221html", properties:{datePublished:datetime('2018-02-27T09:05:00Z'), internalDocId:3899582, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-19T01:11:07Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Full Year And Fourth Quarter 2017 Financial Results"}}, {uri:"https://1145.am/db/2361371/wwwfiercebiotechcom_biotech_paul-l-berns-joins-jazz-pharmaceuticals-board-of-directors", properties:{datePublished:datetime('2010-06-07T14:08:51Z'), internalDocId:2361371, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Paul L. Berns Joins Jazz Pharmaceuticals' Board of Directors"}}, {uri:"https://1145.am/db/3798778/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-third-quarter-2018-financial-results-300745059html", properties:{datePublished:datetime('2018-11-06T21:05:00Z'), internalDocId:3798778, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T19:01:44Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Third Quarter 2018 Financial Results"}}, {uri:"https://1145.am/db/3831638/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-share-repurchase-program-authorization-increase-of-400-million-300762845html", properties:{datePublished:datetime('2018-12-10T21:10:00Z'), internalDocId:3831638, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-18T20:54:42Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Share Repurchase Program Authorization Increase of $400 Million"}}, {uri:"https://1145.am/db/3619527/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-survey-highlights-prevalence-of-misinformation-and-misperception-about-narcolepsy-among-americans-300927608html", properties:{datePublished:datetime('2019-09-30T12:30:00Z'), internalDocId:3619527, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-17T21:56:52Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Survey Highlights Prevalence of Misinformation and Misperception About Narcolepsy Among Americans"}}, {uri:"https://1145.am/db/3615008/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-first-patient-enrolled-in-pivotal-phase-23-study-evaluating-jzp-458-for-the-treatment-of-acute-lymphoblastic-leukemia-or-lymphoblastic-lymphoma-300979651html", properties:{datePublished:datetime('2019-12-30T13:00:00Z'), internalDocId:3615008, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-17T21:42:14Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces First Patient Enrolled in Pivotal Phase 2/3 Study Evaluating JZP-458 for the Treatment of Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma"}}, {uri:"https://1145.am/db/3332618/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-participation-at-upcoming-investor-conferences-301011941html", properties:{datePublished:datetime('2020-02-26T21:05:00Z'), internalDocId:3332618, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-14T03:29:26Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Participation at Upcoming Investor Conferences"}}, {uri:"https://1145.am/db/88496/apnewscom_cdf53282c6c49f22fc75e493509d10f0", properties:{datePublished:datetime('2020-05-05T21:16:38Z'), internalDocId:88496, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Exelixis: 1Q Earnings Snapshot"}}, {uri:"https://1145.am/db/88387/apnewscom_cca59e7fb5aadced6df5a7915caadf76", properties:{datePublished:datetime('2020-05-05T21:39:37Z'), internalDocId:88387, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Jazz: 1Q Earnings Snapshot"}}, {uri:"https://1145.am/db/2354682/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-appoints-head-of-research-and-development", properties:{datePublished:datetime('2011-09-28T16:14:32Z'), internalDocId:2354682, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Appoints Head of Research and Development"}}, {uri:"https://1145.am/db/2353684/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-appoints-head-of-research-and-development-0", properties:{datePublished:datetime('2011-09-28T12:18:55Z'), internalDocId:2353684, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals Appoints Head of Research and Development"}}, {uri:"https://1145.am/db/2575336/wwwfiercepharmacom_pharma_exelixis-appoints-executive-vice-president-and-chief-commercial-officer", properties:{datePublished:datetime('2011-10-25T11:20:24Z'), internalDocId:2575336, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Exelixis Appoints Executive Vice President and Chief Commercial Officer"}}, {uri:"https://1145.am/db/2362082/wwwfiercebiotechcom_biotech_exelixis-appoints-executive-vice-president-and-chief-commercial-officer-0", properties:{datePublished:datetime('2011-10-25T11:20:58Z'), internalDocId:2362082, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Appoints Executive Vice President and Chief Commercial Officer"}}, {uri:"https://1145.am/db/3293699/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-stops-enrollment-in-phase-3-study-evaluating-defibrotide-for-the-prevention-of-veno-occlusive-disease-301049642html", properties:{datePublished:datetime('2020-04-29T20:05:00Z'), internalDocId:3293699, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-14T02:22:50Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Stops Enrollment in Phase 3 Study Evaluating Defibrotide for the Prevention of Veno-Occlusive Disease"}}, {uri:"https://1145.am/db/2363075/wwwfiercebiotechcom_biotech_exelixis-appoints-executive-vice-president-and-chief-commercial-officer", properties:{datePublished:datetime('2011-10-25T16:29:18Z'), internalDocId:2363075, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Appoints Executive Vice President and Chief Commercial Officer"}}, {uri:"https://1145.am/db/107130/wwwreuterscom_article_us-health-coronavirus-moderna-idUSKBN23I1RG", properties:{datePublished:datetime('2020-06-11T15:26:42Z'), internalDocId:107130, deletedRedundantSameAsAt:1, sourceOrganization:"Reuters", headline:"Moderna to start final testing stage of coronavirus vaccine in July"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{uri:"https://1145.am/db/2592814/wwwfiercepharmacom_pharma_jazz-pharmaceuticals-plc-announces-new-executive-appointments", properties:{datePublished:datetime('2012-01-25T15:38:24Z'), internalDocId:2592814, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz Pharmaceuticals plc Announces New Executive Appointments"}}, {uri:"https://1145.am/db/3197616/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-webcast-for-xywav-investor-update-301155108html", properties:{datePublished:datetime('2020-10-19T20:15:00Z'), internalDocId:3197616, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-13T23:56:45Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Webcast for Xywav Investor Update"}}, {uri:"https://1145.am/db/3197581/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-to-report-2020-third-quarter-financial-results-on-november-2-2020-301155061html", properties:{datePublished:datetime('2020-10-19T20:05:00Z'), internalDocId:3197581, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-13T23:56:41Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals to Report 2020 Third Quarter Financial Results on November 2, 2020"}}, {uri:"https://1145.am/db/2586978/wwwfiercepharmacom_pharma_catherine-sohn-elected-to-jazz-pharmaceuticals-board-of-directors", properties:{datePublished:datetime('2012-07-31T01:07:51Z'), internalDocId:2586978, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Catherine Sohn Elected To Jazz Pharmaceuticals Board Of Directors"}}, {uri:"https://1145.am/db/3395819/wwwbusinessinsidercom_modernas-5-biggest-vaccine-programs-after-covid-19-2021-4", properties:{datePublished:datetime('2021-04-14T00:00:00Z'), internalDocId:3395819, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-17T15:04:47Z'), sourceOrganization:"Business Insider", headline:"Moderna is betting its mRNA technology will lead to a new wave of vaccines for diseases like HIV. Here are the top 5 it's working on beyond COVID-19."}}, {uri:"https://1145.am/db/3413145/wwwbusinessinsidercom_insiders-top-healthcare-stories-for-april-20-2021-4", properties:{datePublished:datetime('2021-04-20T00:00:00Z'), internalDocId:3413145, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-17T15:32:23Z'), sourceOrganization:"Business Insider", headline:"We mapped out the key changes among Walmart's healthcare leadership"}}, {uri:"https://1145.am/db/2279215/wwwfiercebiotechcom_biotech_moderna-hoping-to-prove-it-s-no-one-trick-covid-pony-posts-early-peek-at-mrna-flu-shot", properties:{datePublished:datetime('2021-12-10T13:10:00Z'), internalDocId:2279215, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Moderna, hoping to prove it's no one-trick COVID pony, posts early peek at mRNA flu shot hopeful"}}, {uri:"https://1145.am/db/4915910/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-presents-positive-interim-phase-23-results-of-rylaze-asparaginase-erwinia-chrysanthemi-recombinant-rywn-in-acute-lymphoblastic-leukemia-or-lymphoblastic-lymphoma-at-ash-2021-annual-meeting-301442693html", properties:{datePublished:datetime('2021-12-12T14:00:00Z'), internalDocId:4915910, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-05T08:26:13Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Presents Positive Interim Phase 2/3 Results of Rylaze (asparaginase erwinia chrysanthemi (recombinant)-rywn) in Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma at ASH 2021 Annual Meeting"}}, {uri:"https://1145.am/db/4921170/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-first-patient-enrolled-in-phase-2b-clinical-trial-evaluating-novel-suvecaltamide-jzp385-for-once-daily-treatment-of-adults-with-essential-tremor-301445163html", properties:{datePublished:datetime('2021-12-15T12:45:00Z'), internalDocId:4921170, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-05T08:47:47Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces First Patient Enrolled in Phase 2b Clinical Trial Evaluating Novel Suvecaltamide (JZP385) for Once-Daily Treatment of Adults with Essential Tremor"}}, {uri:"https://1145.am/db/4819592/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-vision-2025-to-deliver-sustainable-growth-and-enhanced-value-to-drive-transformation-to-innovative-global-biopharmaceutical-leader-301456903html", properties:{datePublished:datetime('2022-01-10T12:30:00Z'), internalDocId:4819592, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T19:55:27Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Vision 2025 to Deliver Sustainable Growth and Enhanced Value to Drive Transformation to Innovative, Global Biopharmaceutical Leader"}}, {uri:"https://1145.am/db/836435/wwwreuterscom_business_healthcare-pharmaceuticals_moderna-eyes-covid-booster-by-august-not-clear-yet-if-omicron-specific-needed-2022-02-16", properties:{datePublished:datetime('2022-02-16T23:06:07.178Z'), internalDocId:836435, deletedRedundantSameAsAt:1, sourceOrganization:"Reuters", headline:"Moderna eyes COVID booster by August, not clear yet if Omicron-specific needed"}}, {uri:"https://1145.am/db/844038/apnewscom_article_business-california-earnings-exelixis-inc-5923f31b2f1d607406488f8f6bb5cf72", properties:{datePublished:datetime('2022-02-17T22:09:43Z'), internalDocId:844038, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Exelixis: Q4 Earnings Snapshot"}}, {uri:"https://1145.am/db/856895/apnewscom_article_business-earnings-massachusetts-moderna-inc-fd2153a3ed3455abc19ec05c40e60be6", properties:{datePublished:datetime('2022-02-24T13:54:41Z'), internalDocId:856895, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Moderna: Q4 Earnings Snapshot"}}, {uri:"https://1145.am/db/4799641/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-full-year-and-fourth-quarter-2021-financial-results-301492977html", properties:{datePublished:datetime('2022-03-01T21:05:00Z'), internalDocId:4799641, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T18:48:41Z'), sourceOrganization:"PR Newswire", headline:"JAZZ PHARMACEUTICALS ANNOUNCES FULL YEAR AND FOURTH QUARTER 2021 FINANCIAL RESULTS"}}, {uri:"https://1145.am/db/871515/apnewscom_article_business-earnings-jazz-pharmaceuticals-plc-ffbca378de70a7b91f4da31f15ab4b24", properties:{datePublished:datetime('2022-03-01T21:42:03Z'), internalDocId:871515, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Jazz: Q4 Earnings Snapshot"}}, {uri:"https://1145.am/db/4808186/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-first-quarter-2022-financial-results-and-raises-2022-financial-guidance-301539932html", properties:{datePublished:datetime('2022-05-04T20:10:00Z'), internalDocId:4808186, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-11-04T19:17:33Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces First Quarter 2022 Financial Results and Raises 2022 Financial Guidance"}}, {uri:"https://1145.am/db/1032794/apnewscom_article_business-earnings-jazz-pharmaceuticals-plc-eb5300a7c350615af1fb4447e909a7b3", properties:{datePublished:datetime('2022-05-04T20:56:37Z'), internalDocId:1032794, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Jazz: Q1 Earnings Snapshot"}}, {uri:"https://1145.am/db/1053044/apnewscom_article_business-california-earnings-exelixis-inc-e54113e535cdbda173b57b44593e778a", properties:{datePublished:datetime('2022-05-10T20:16:37Z'), internalDocId:1053044, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Exelixis: Q1 Earnings Snapshot"}}, {uri:"https://1145.am/db/1465700/apnewscom_article_earnings-1491e6a0db0cac88a611b65ff0f1474a", properties:{datePublished:datetime('2022-11-01T20:47:17Z'), internalDocId:1465700, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Exelixis: Q3 Earnings Snapshot"}}, {uri:"https://1145.am/db/1494821/apnewscom_article_earnings-4b89b3976016c86a26161a20d7878114", properties:{datePublished:datetime('2022-11-09T21:29:34Z'), internalDocId:1494821, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Jazz: Q3 Earnings Snapshot"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{uri:"https://1145.am/db/1580058/wwwreuterscom_business_healthcare-pharmaceuticals_japan-unit-britains-jazz-pharma-starts-phase-iii-trial-cannabis-drug-2022-12-15", properties:{datePublished:datetime('2022-12-15T09:42:06.79Z'), internalDocId:1580058, deletedRedundantSameAsAt:1, sourceOrganization:"Reuters", headline:"Japan unit of Britain's Jazz Pharma starts phase III trial of cannabis drug"}}, {uri:"https://1145.am/db/2566334/wwwfiercepharmacom_pharma_jazz-wins-reimbursement-nod-nice-cannabidiol-product-epidyolex", properties:{datePublished:datetime('2023-02-01T16:52:00Z'), internalDocId:2566334, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz wins reimbursement nod from NICE for cannabinoid med Epidyolex"}}, {uri:"https://1145.am/db/1665696/apnewscom_article_automated-insights-earnings-exelixis-inc-california-business-c7bf94c8e366407bb9d62739d535e803", properties:{datePublished:datetime('2023-02-07T21:59:03Z'), internalDocId:1665696, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Exelixis: Q4 Earnings Snapshot"}}, {uri:"https://1145.am/db/4711766/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-to-report-2022-fourth-quarter-and-full-year-financial-results-on-march-1-2023-301747989html", properties:{datePublished:datetime('2023-02-15T21:15:00Z'), internalDocId:4711766, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-10-29T23:06:17Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals to Report 2022 Fourth Quarter and Full Year Financial Results on March 1, 2023"}}, {uri:"https://1145.am/db/1688580/apnewscom_article_earnings-d3e1bce4b81a644fb4c343824f2e20bb", properties:{datePublished:datetime('2023-03-01T21:42:25Z'), internalDocId:1688580, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Jazz: Q4 Earnings Snapshot"}}, {uri:"https://1145.am/db/4755389/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-to-report-2023-first-quarter-financial-results-on-may-10-2023-301807430html", properties:{datePublished:datetime('2023-04-26T20:15:00Z'), internalDocId:4755389, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-10-30T02:00:43Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals to Report 2023 First Quarter Financial Results on May 10, 2023"}}, {uri:"https://1145.am/db/2000089/apnewscom_article_earnings-c178be20bd1d81e872d318321290090c", properties:{datePublished:datetime('2023-05-09T21:58:32Z'), internalDocId:2000089, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Exelixis: Q1 Earnings Snapshot"}}, {uri:"https://1145.am/db/2001582/apnewscom_article_earnings-740c1de983de00851d11ecd0e966d0fd", properties:{datePublished:datetime('2023-05-10T20:36:07Z'), internalDocId:2001582, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Jazz: Q1 Earnings Snapshot"}}, {uri:"https://1145.am/db/4745705/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-to-host-zanidatamab-kol-investor-webcast-on-june-2-2023-301834916html", properties:{datePublished:datetime('2023-05-25T20:15:00Z'), internalDocId:4745705, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-10-30T01:20:47Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals to Host Zanidatamab KOL Investor Webcast on June 2, 2023"}}, {uri:"https://1145.am/db/4752621/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-to-report-2023-second-quarter-financial-results-on-august-9-2023-301886520html", properties:{datePublished:datetime('2023-07-26T20:15:00Z'), internalDocId:4752621, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-10-30T01:49:16Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals to Report 2023 Second Quarter Financial Results on August 9, 2023"}}, {uri:"https://1145.am/db/1254565/apnewscom_article_earnings-jazz-pharmaceuticals-plc-d5cd71c219023eac16411ba256e47d88", properties:{datePublished:datetime('2022-08-03T21:18:49Z'), internalDocId:1254565, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Jazz: Q2 Earnings Snapshot"}}, {uri:"https://1145.am/db/1270356/apnewscom_article_earnings-1932f84935025ec08c9caa753058029f", properties:{datePublished:datetime('2022-08-09T20:58:03Z'), internalDocId:1270356, deletedRedundantSameAsAt:1, sourceOrganization:"Associated Press", headline:"Exelixis: Q2 Earnings Snapshot"}}, {uri:"https://1145.am/db/4751644/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-to-present-at-the-42nd-annual-jp-morgan-healthcare-conference-302019557html", properties:{datePublished:datetime('2023-12-20T21:15:00Z'), internalDocId:4751644, deletedRedundantSameAsAt:1.740529705680305E9, dateRetrieved:datetime('2024-10-30T01:45:28Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference"}}, {uri:"https://1145.am/db/4644127/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-to-host-virtual-zanidatamab-rd-day-on-tuesday-march-19-2024-302087115html", properties:{datePublished:datetime('2024-03-12T20:15:00Z'), internalDocId:4644127, deletedRedundantSameAsAt:1.740529705680305E9, dateRetrieved:datetime('2024-10-29T17:54:37Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals to Host Virtual Zanidatamab R&D Day on Tuesday, March 19, 2024"}}, {uri:"https://1145.am/db/2353195/wwwfiercebiotechcom_financials_biotech-legend-termeer-joins-board-at-moderna", properties:{datePublished:datetime('2013-04-30T14:52:26Z'), internalDocId:2353195, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Biotech legend Termeer joins the board at Moderna"}}, {uri:"https://1145.am/db/2353227/wwwfiercebiotechcom_biotech_henri-a-termeer-joins-moderna-therapeutics-board-of-directors", properties:{datePublished:datetime('2013-05-01T18:55:08Z'), internalDocId:2353227, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Henri A. Termeer Joins Moderna Therapeutics Board of Directors"}}, {uri:"https://1145.am/db/2545689/wwwfiercepharmacom_pharma_trial-failure-jazzs-cannabis-derived-drug-blunts-goal-expand-its-use-us", properties:{datePublished:datetime('2022-06-28T14:35:00Z'), internalDocId:2545689, deletedRedundantSameAsAt:1.7406036189731367E9, sourceOrganization:"Fierce Pharma", headline:"Trial failure for Jazz's cannabis-derived drug blunts goal to expand its use to US"}}, {uri:"https://1145.am/db/4712964/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-presents-updated-phase-2a-data-at-sabcs-2023-showcasing-potential-of-zanidatamab-in-her2hr-metastatic-breast-cancer-302010341html", properties:{datePublished:datetime('2023-12-08T18:20:00Z'), internalDocId:4712964, deletedRedundantSameAsAt:1.7406036189731367E9, dateRetrieved:datetime('2024-10-29T23:12:34Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Presents Updated Phase 2a Data at SABCS 2023 Showcasing Potential of Zanidatamab in HER2+/HR+ Metastatic Breast Cancer"}}, {uri:"https://1145.am/db/3493383/wwwbusinessinsidercom_coronavirus-vaccine-funding-deal-for-moderna-from-barda-2020-4", properties:{datePublished:datetime('2020-04-16T00:00:00Z'), internalDocId:3493383, deletedRedundantSameAsAt:1, dateRetrieved:datetime('2024-01-17T17:44:13Z'), sourceOrganization:"Business Insider", headline:"Moderna's potential coronavirus vaccine just got a huge funding boost from the US government"}}, {uri:"https://1145.am/db/4691380/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-second-quarter-2024-financial-results-and-updates-2024-financial-guidance-302211459html", properties:{datePublished:datetime('2024-07-31T20:05:00Z'), internalDocId:4691380, deletedRedundantSameAsAt:1.7407685593746521E9, dateRetrieved:datetime('2024-10-29T20:18:48Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{uri:"https://1145.am/db/4691359/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-second-quarter-2024-financial-results-and-updates-2024-financial-guidance-302211410html", properties:{datePublished:datetime('2024-07-31T20:05:00Z'), internalDocId:4691359, deletedRedundantSameAsAt:1.7407685593746521E9, dateRetrieved:datetime('2024-10-29T20:18:42Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Second Quarter 2024 Financial Results and Updates 2024 Financial Guidance"}}, {uri:"https://1145.am/db/4667444/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-provides-update-on-cannabidiol-oral-solution-phase-3-trial-in-japan-in-treatment-resistant-epilepsies-302228873html", properties:{datePublished:datetime('2024-08-22T20:05:00Z'), internalDocId:4667444, deletedRedundantSameAsAt:1.7408307770675957E9, dateRetrieved:datetime('2024-10-29T19:04:38Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Provides Update on Cannabidiol Oral Solution Phase 3 Trial in Japan in Treatment-Resistant Epilepsies"}}, {uri:"https://1145.am/db/4941758/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-third-quarter-2024-financial-results-302297903html", properties:{datePublished:datetime('2024-11-06T21:05:00Z'), internalDocId:4941758, deletedRedundantSameAsAt:1.7410094788502004E9, dateRetrieved:datetime('2024-11-06T21:53:19Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results"}}, {uri:"https://1145.am/db/4941753/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-third-quarter-2024-financial-results-302297961html", properties:{datePublished:datetime('2024-11-06T21:05:00Z'), internalDocId:4941753, deletedRedundantSameAsAt:1.7410094788502004E9, dateRetrieved:datetime('2024-11-06T21:53:19Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Third Quarter 2024 Financial Results"}}, {uri:"https://1145.am/db/4988653/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-to-participate-in-citis-2024-global-healthcare-conference-302310546html", properties:{datePublished:datetime('2024-11-19T21:05:00Z'), internalDocId:4988653, deletedRedundantSameAsAt:1.7410094788502004E9, dateRetrieved:datetime('2024-11-19T21:13:19Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals to Participate in Citi's 2024 Global Healthcare Conference"}}, {uri:"https://1145.am/db/159841/wwwreuterscom_article_us-health-coronavirus-finance-breakingvi-idUSKBN28C342", properties:{datePublished:datetime('2020-12-02T16:41:34Z'), internalDocId:159841, deletedRedundantSameAsAt:1, sourceOrganization:"Reuters", headline:"Corona Capital: Tui bonds, Perfume comeback"}}, {uri:"https://1145.am/db/5273410/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-announces-full-year-and-fourth-quarter-2024-financial-results-and-provides-2025-financial-guidance-302385001html", properties:{datePublished:datetime('2025-02-25T21:05:00Z'), internalDocId:5273410, deletedRedundantSameAsAt:1.741096690458789E9, dateRetrieved:datetime('2025-02-27T14:38:01Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals Announces Full Year and Fourth Quarter 2024 Financial Results and Provides 2025 Financial Guidance"}}, {uri:"https://1145.am/db/5297853/wwwglobenewswirecom_news-release_2025_03_05_3037278_25619_en_Jazz-Pharmaceuticals-to-Acquire-Chimerix-Further-Diversifying-Oncology-Portfoliohtml", properties:{datePublished:datetime('2025-03-05T12:00:00Z'), internalDocId:5297853, deletedRedundantSameAsAt:1.741249911350312E9, dateRetrieved:datetime('2025-03-06T06:35:47Z'), sourceOrganization:"GlobeNewswire", headline:"Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio"}}, {uri:"https://1145.am/db/5301824/wwwprnewswirecom_news-releases_jazz-pharmaceuticals-to-acquire-chimerix-further-diversifying-oncology-portfolio-302393029html", properties:{datePublished:datetime('2025-03-05T12:00:00Z'), internalDocId:5301824, deletedRedundantSameAsAt:1.7413416403251095E9, dateRetrieved:datetime('2025-03-06T20:25:02Z'), sourceOrganization:"PR Newswire", headline:"Jazz Pharmaceuticals to Acquire Chimerix, Further Diversifying Oncology Portfolio"}}, {uri:"https://1145.am/db/221697/wwwreuterscom_article_us-gw-pharma-m-a-jazz-pharms-idUSKBN2A31RM", properties:{datePublished:datetime('2021-02-03T19:44:03Z'), internalDocId:221697, deletedRedundantSameAsAt:1, sourceOrganization:"Reuters", headline:"Jazz Pharma to buy GW Pharma for $7.2 bln, adding cannabis-based drug to portfolio"}}, {uri:"https://1145.am/db/2316643/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-inc-announces-expansion-of-senior-debt", properties:{datePublished:datetime('2008-03-18T11:19:33Z'), internalDocId:2316643, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals, Inc. Announces Expansion of Senior Debt"}}, {uri:"https://1145.am/db/2214553/wwwfiercehealthcarecom_healthcare_exelixis-announces-june-5-webcast-conference-call-regarding-its-150-million-funding", properties:{datePublished:datetime('2008-06-05T11:22:53Z'), internalDocId:2214553, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Healthcare", headline:"Exelixis Announces June 5 Webcast of Conference Call Regarding Its $150 Million Funding Commitment from Deerfield Management"}}, {uri:"https://1145.am/db/2351047/wwwfiercebiotechcom_financials_exelixis-appoints-executive-vice-president-and-general-counsel", properties:{datePublished:datetime('2014-02-14T12:54:44Z'), internalDocId:2351047, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Exelixis Appoints Executive Vice President and General Counsel"}}, {uri:"https://1145.am/db/2354140/wwwfiercebiotechcom_biotech_jazz-pharmaceuticals-plc-jazz-announces-management-change", properties:{datePublished:datetime('2014-02-28T13:39:07Z'), internalDocId:2354140, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Biotech", headline:"Jazz Pharmaceuticals plc (JAZZ) Announces Management Change"}}, {uri:"https://1145.am/db/2593496/wwwfiercepharmacom_corporate_jazz-pharmaceuticals-names-russell-j-cox-to-position-of-chief-operating-officer", properties:{datePublished:datetime('2014-05-20T15:12:22Z'), internalDocId:2593496, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz Pharmaceuticals Names Russell J. Cox To Position Of Chief Operating Officer"}}, {uri:"https://1145.am/db/2594219/wwwfiercepharmacom_pharma_jazz-pharmaceuticals-plc-jazz-names-russell-j-cox-to-position-of-chief-operating-officer", properties:{datePublished:datetime('2014-05-23T11:48:05Z'), internalDocId:2594219, deletedRedundantSameAsAt:1, sourceOrganization:"Fierce Pharma", headline:"Jazz Pharmaceuticals plc (JAZZ) Names Russell J. Cox To Position Of Chief Operating Officer"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{start: {uri:"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"}, end: {uri:"https://1145.am/db/geonames_location/2635167"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"}, end: {uri:"https://1145.am/db/geonames_location/4192205"}, properties:{weight:2}}, {start: {uri:"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"}, end: {uri:"https://1145.am/db/geonames_location/4464368"}, properties:{weight:2}}, {start: {uri:"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"}, end: {uri:"https://1145.am/db/geonames_location/2964574"}, properties:{weight:74}}, {start: {uri:"https://1145.am/db/88496/Exelixis_Inc"}, end: {uri:"https://1145.am/db/geonames_location/5322737"}, properties:{weight:7}}, {start: {uri:"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"}, end: {uri:"https://1145.am/db/geonames_location/1645457"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"}, end: {uri:"https://1145.am/db/geonames_location/3993763"}, properties:{weight:2}}, {start: {uri:"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"}, end: {uri:"https://1145.am/db/geonames_location/5128581"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"}, end: {uri:"https://1145.am/db/geonames_location/5380748"}, properties:{weight:10}}, {start: {uri:"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"}, end: {uri:"https://1145.am/db/geonames_location/2963597"}, properties:{weight:4}}, {start: {uri:"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"}, end: {uri:"https://1145.am/db/geonames_location/3042142"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"}, end: {uri:"https://1145.am/db/geonames_location/2643743"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/88496/Exelixis_Inc"}, end: {uri:"https://1145.am/db/geonames_location/5397765"}, properties:{weight:34}}, {start: {uri:"https://1145.am/db/88496/Exelixis_Inc"}, end: {uri:"https://1145.am/db/geonames_location/4887398"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/88496/Exelixis_Inc"}, end: {uri:"https://1145.am/db/geonames_location/5391959"}, properties:{weight:5}}, {start: {uri:"https://1145.am/db/90949/Moderna"}, end: {uri:"https://1145.am/db/geonames_location/4931972"}, properties:{weight:15}}, {start: {uri:"https://1145.am/db/90949/Moderna"}, end: {uri:"https://1145.am/db/geonames_location/2077456"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/90949/Moderna"}, end: {uri:"https://1145.am/db/geonames_location/4930956"}, properties:{weight:3}}, {start: {uri:"https://1145.am/db/90949/Moderna"}, end: {uri:"https://1145.am/db/geonames_location/6251999"}, properties:{weight:2}}, {start: {uri:"https://1145.am/db/90949/Moderna"}, end: {uri:"https://1145.am/db/geonames_location/5391959"}, properties:{weight:1}}] AS row
            MATCH (start:Resource{uri: row.start.uri})
            MATCH (end:Resource{uri: row.end.uri})
            CREATE (start)-[r:basedInHighGeoNamesLocation]->(end) SET r += row.properties;
            UNWIND [{start: {uri:"https://1145.am/db/90949/Moderna"}, end: {uri:"https://1145.am/db/geonames_location/6254926"}, properties:{weight:2}}, {start: {uri:"https://1145.am/db/90949/Moderna"}, end: {uri:"https://1145.am/db/geonames_location/6252001"}, properties:{weight:2}}, {start: {uri:"https://1145.am/db/90949/Moderna"}, end: {uri:"https://1145.am/db/geonames_location/4158928"}, properties:{weight:1}}] AS row
            MATCH (start:Resource{uri: row.start.uri})
            MATCH (end:Resource{uri: row.end.uri})
            CREATE (start)-[r:basedInHighGeoNamesLocation]->(end) SET r += row.properties;""".split(";")
        for query in queries:
            if query is None or query.strip() == "":
                continue
            db.cypher_query(query)
        R = RDFPostProcessor()
        R.run_all_in_order()
        refresh_geo_data(fill_blanks=False)

    def test_does_not_find_org_with_low_relative_weight(self):
        query = """MATCH (o: Resource&Organization)-[b:basedInHighGeoNamesLocation]-(x:GeoNamesLocation) where x.admin1Code = 'CA' and x.countryCode = 'US' return o.uri, b.weight"""
        res,_ = db.cypher_query(query)
        as_set = set( [tuple(x) for x in res])
        # DB has Moderna in US-CA with weight of 1
        assert as_set == {('https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc', 10), ('https://1145.am/db/88496/Exelixis_Inc', 5), 
                            ('https://1145.am/db/88496/Exelixis_Inc', 34), ('https://1145.am/db/88496/Exelixis_Inc', 7), 
                            ('https://1145.am/db/90949/Moderna', 1) }, f"Got {as_set}"
        ca_uris = org_uris_by_industry_id_and_or_geo_code(None, "US-CA")
        us_ca_as_set = set([x[0] for x in ca_uris])
        assert us_ca_as_set == {'https://1145.am/db/88496/Exelixis_Inc'}, f"Got {us_ca_as_set}"
        ie_uris = org_uris_by_industry_id_and_or_geo_code(None, "IE")
        ie_as_set = set([x[0] for x in ie_uris])
        assert ie_as_set == {"https://1145.am/db/88387/Jazz_Pharmaceuticals_Plc"}, f"Got {ie_as_set}"

    def test_org_does_not_include_low_relative_weight_locs(self):
        query="MATCH (o: Resource&Organization {uri:'https://1145.am/db/90949/Moderna'})-[b:basedInHighGeoNamesLocation]->(l:GeoNamesLocation) RETURN o.uri, b.weight, l.uri"
        res, _ = db.cypher_query(query)
        sum_of_weights = sum([x[1] for x in res])
        high_weight_matches = [x[2] for x in res if x[1] >= GEO_LOCATION_MIN_WEIGHT_PROPORTION * sum_of_weights]
        low_weight_matches = [x[2] for x in res if x[1] < GEO_LOCATION_MIN_WEIGHT_PROPORTION * sum_of_weights]
        org = Resource.get_by_uri('https://1145.am/db/90949/Moderna')
        all_based_in_uris = [x.uri for x in org.internal_basedInHighGeoNamesLocation]
        assert set(all_based_in_uris) == set(high_weight_matches + low_weight_matches)
        high_weight_based_in_uris = [x.uri for x in org.basedInHighGeoNamesLocation]
        assert set(high_weight_based_in_uris) == set(high_weight_matches)


class TestActivityHelpers(TestCase):

    @classmethod
    def setUpTestData(cls) -> None:
        '''
        based on 
        call apoc.export.cypher.query('match (o: Resource&Organization)-[t:productActivity]-(n: Resource {uri:"https://1145.am/db/5304143/Launch-Tabasco_Brand_Salsa_Picante"})-[d:documentSource]-(a: Article), (a)-[:url]-(u) return *',null,{format: "plain", stream:true})
        '''
        queries = """CREATE CONSTRAINT n10s_unique_uri IF NOT EXISTS  FOR (node:Resource) REQUIRE (node.uri) IS UNIQUE;
            UNWIND [{uri:"https://1145.am/db/5304143/Launch-Tabasco_Brand_Salsa_Picante", properties:{documentDate:datetime('2025-03-06T20:16:00Z'), deletedRedundantSameAsAt:1.7413416403251095E9, when:[localdatetime('2025-03-06T00:00:00')], whenRaw:["March 6, 2025"], productName:["TABASCO Brand Salsa Picante"], whereHighRaw:["AVERY ISLAND, La."], whereHighClean:["Avery Island"], internalDocId:5304143, documentExtract:"AVERY ISLAND, La., March 6, 2025 /PRNewswire/ - McIlhenny Company, the makers of TABASCO Brand Pepper Sauce, brings bold new flavor to the foodservice industry with the launch of TABASCO Brand Salsa Picante. As the brand's first-ever Mexican-style hot sauce, TABASCO Salsa Picante delivers a rich, thick texture, a vibrant spice blend, and a subtle kick of heat. Crafted with over 155 years of pepper expertise, this new sauce meets the high standards foodservice operators and their guests have come to expect from TABASCO Brand. Tabasco Brand Salsa Picante packaging. Available in an easy-to-squeeze 16.2-oz.", foundName:["launch"], name:["launch"], status:["completed"]}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:ProductActivity;
            UNWIND [{uri:"https://www.prnewswire.com/news-releases/tabasco-brand-launches-new-mexican-style-hot-sauce-for-foodservice-302395079.html", properties:{deletedRedundantSameAsAt:1.7413416403251095E9}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties;
            UNWIND [{uri:"https://1145.am/db/2707859/McIlhenny_Company", properties:{internalDocId:2707859, deletedRedundantSameAsAt:1, foundName:["McIlhenny Company"], name:["McIlhenny Company"], basedInLowRaw:["Louisiana"]}}, {uri:"https://1145.am/db/5304143/McIlhenny_Company", properties:{basedInHighClean:["Avery Island"], internalDocId:5304143, deletedRedundantSameAsAt:1.7413416403251095E9, foundName:["McIlhenny Company"], name:["McIlhenny Company"], internalMergedSameAsHighToUri:"https://1145.am/db/2707859/McIlhenny_Company", basedInHighRaw:["AVERY ISLAND, La."]}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Organization;
            UNWIND [{uri:"https://1145.am/db/5304143/wwwprnewswirecom_news-releases_tabasco-brand-launches-new-mexican-style-hot-sauce-for-foodservice-302395079html", properties:{datePublished:datetime('2025-03-06T20:16:00Z'), internalDocId:5304143, deletedRedundantSameAsAt:1.7413416403251095E9, dateRetrieved:datetime('2025-03-06T22:09:18Z'), sourceOrganization:"Hawai\\'i \\"Public] (Radio", headline:"TABASCO BRAND LAUNCHES NEW MEXICAN-STYLE HOT SAUCE FOR FOODSERVICE"}}] AS row
            CREATE (n:Resource{uri: row.uri}) SET n += row.properties SET n:Article;
            UNWIND [{start: {uri:"https://1145.am/db/5304143/McIlhenny_Company"}, end: {uri:"https://1145.am/db/5304143/Launch-Tabasco_Brand_Salsa_Picante"}, properties:{weight:1}}, {start: {uri:"https://1145.am/db/2707859/McIlhenny_Company"}, end: {uri:"https://1145.am/db/5304143/Launch-Tabasco_Brand_Salsa_Picante"}, properties:{weight:1}}] AS row
            MATCH (start:Resource{uri: row.start.uri})
            MATCH (end:Resource{uri: row.end.uri})
            CREATE (start)-[r:productActivity]->(end) SET r += row.properties;
            UNWIND [{start: {uri:"https://1145.am/db/5304143/Launch-Tabasco_Brand_Salsa_Picante"}, end: {uri:"https://1145.am/db/5304143/wwwprnewswirecom_news-releases_tabasco-brand-launches-new-mexican-style-hot-sauce-for-foodservice-302395079html"}, properties:{documentExtract:"AVERY ISLAND, La., March 6, 2025 /PRNewswire/ - McIlhenny Company, the makers of TABASCO Brand Pepper Sauce, brings bold new flavor to the foodservice industry with the launch of TABASCO Brand Salsa Picante. As the brand's first-ever Mexican-style hot sauce, TABASCO Salsa Picante delivers a rich, thick texture, a vibrant spice blend, and a subtle kick of heat. Crafted with over 155 years of pepper expertise, this new sauce meets the high standards foodservice operators and their guests have come to expect from TABASCO Brand. Tabasco Brand Salsa Picante packaging. Available in an easy-to-squeeze 16.2-oz.", weight:1}}, {start: {uri:"https://1145.am/db/2707859/McIlhenny_Company"}, end: {uri:"https://1145.am/db/5304143/wwwprnewswirecom_news-releases_tabasco-brand-launches-new-mexican-style-hot-sauce-for-foodservice-302395079html"}, properties:{weight: 1}}] AS row
            MATCH (start:Resource{uri: row.start.uri})
            MATCH (end:Resource{uri: row.end.uri})
            CREATE (start)-[r:documentSource]->(end) SET r += row.properties;
            UNWIND [{start: {uri:"https://1145.am/db/5304143/wwwprnewswirecom_news-releases_tabasco-brand-launches-new-mexican-style-hot-sauce-for-foodservice-302395079html"}, end: {uri:"https://www.prnewswire.com/news-releases/tabasco-brand-launches-new-mexican-style-hot-sauce-for-foodservice-302395079.html"}, properties:{weight: 1}}] AS row
            MATCH (start:Resource{uri: row.start.uri})
            MATCH (end:Resource{uri: row.end.uri})
            CREATE (start)-[r:url]->(end) SET r += row.properties;
            """.split(";")
        clean_db()
        nuke_cache()
        for query in queries:
            if query is None or query.strip() == "":
                continue
            db.cypher_query(query)           

    def test_does_not_include_merged_orgs(self):
        activity_uri = "https://1145.am/db/5304143/Launch-Tabasco_Brand_Salsa_Picante"
        act = Resource.get_by_uri(activity_uri)
        assert len(act.productOrganization) == 2   
        article_uri = "https://1145.am/db/5304143/wwwprnewswirecom_news-releases_tabasco-brand-launches-new-mexican-style-hot-sauce-for-foodservice-302395079html"
        pub_date = date.fromisoformat("2025-03-06")
        act_arts = [(activity_uri, article_uri, pub_date)]
        res = activity_articles_to_api_results(act_arts)
        assert len(res[0]['actors']['organization']) == 1
        val = res[0]['actors']['organization'].pop()
        assert val.uri == 'https://1145.am/db/2707859/McIlhenny_Company'

    def test_handles_quote_in_source_name(self):
        source_name = """Hawai'i "Public] (Radio"""
        acts = activities_by_source(source_name, date(2025,3,1), date(2025,3,10))
        assert len(acts) == 1 

class TestVersionableCache(TestCase):

    # node_data1 = [
    #     {"doc_id":95, "identifier":"uspa1","node_type":"Organization","datestamp":datestamp}, # US-PA
    #     {"doc_id":96, "identifier":"uspa2","node_type":"Organization","datestamp":datestamp}, # US-PA
    #     {"doc_id":95, "identifier":"act1","node_type":"OperationsActivity","datestamp":datestamp},
    #     {"doc_id":96, "identifier":"act2","node_type":"OperationsActivity","datestamp":datestamp},
    #     {"doc_id":99, "identifier":"uspaloc","node_type":"GeoNamesLocation","datestamp":datestamp},
    # ]
    # nodes1 = ", ".join([make_node(**x) for x in node_data1])
    # query = f"""CREATE {nodes1},
    # (uspa1)-[:hasOperationsActivity {{weight:2}}]->(act1),
    # (uspa2)-[:hasOperationsActivity {{weight:2}}]->(act2),
    # (uspa1)-[:basedInHighGeoNamesLocation {{weight:2}}]->(uspaloc),
    # (uspa2)-[:basedInHighGeoNamesLocation {{weight:2}}]->(uspaloc),
    # (act1)-[:whereHighGeoNamesLocation {{weight:2}}]->(uspaloc),
    # (act2)-[:whereHighGeoNamesLocation {{weight:2}}]->(uspaloc)"""
    # Above was used to generate query1, but each node has its own Article source. The org search functions
    # need Org and Activity to share the same Article, so manually updated the query as below:
    query1 = """CREATE
        (uspa1:Resource:Organization {uri: 'https://1145.am/db/95/uspa1', name: ['Name USPA1'], industry: ['baz'],   internalDocId: 95})-[:documentSource ]->(docsource_uspa1:Resource:Article {uri: 'https://1145.am/db/article_uspa1',
                        headline: 'Headline uspa1', internalDocId: 95, sourceOrganization:'prweb', datePublished: datetime('2025-08-15T23:59:59.999999+00:00') }), (docsource_uspa1)-[:url]->(ext_uspa1:Resource { uri: 'https://example.org/external/art_uspa1' }), 
                        (act1:Resource:OperationsActivity {uri: 'https://1145.am/db/95/act1', name: ['Name ACT1'],  status: ['some status'],   internalDocId: 95})-[:documentSource { documentExtract: 'Doc Extract ' }]->(docsource_uspa1),
                        
        (uspa2:Resource:Organization {uri: 'https://1145.am/db/96/uspa2', name: ['Name USPA2'], industry: ['baz'],   internalDocId: 96})-[:documentSource ]->(docsource_uspa2:Resource:Article {uri: 'https://1145.am/db/article_uspa2',
                        headline: 'Headline uspa2', internalDocId: 96, sourceOrganization:'prweb', datePublished: datetime('2025-08-15T23:59:59.999999+00:00') }), (docsource_uspa2)-[:url]->(ext_uspa2:Resource { uri: 'https://example.org/external/art_uspa2' }), 
                        (act2:Resource:OperationsActivity {uri: 'https://1145.am/db/96/act2', name: ['Name ACT2'],  status: ['some status'],   internalDocId: 96})-[:documentSource { documentExtract: 'Doc Extract ' }]->(docsource_uspa2), 
                        
        (uspaloc:Resource:GeoNamesLocation {uri: 'https://1145.am/db/99/uspaloc', name: ['Name USPALOC'],    countryCode: 'US',   admin1Code: 'PA',  internalDocId: 99})-[:documentSource ]->(docsource_uspaloc:Resource:Article {uri: 'https://1145.am/db/article_uspaloc',
                        headline: 'Headline uspaloc', internalDocId: 99, sourceOrganization:'prweb', datePublished: datetime('2025-08-15T23:59:59.999999+00:00') }), (docsource_uspaloc)-[:url]->(ext_uspaloc:Resource { uri: 'https://example.org/external/art_uspaloc' }),
        (uspa1)-[:hasOperationsActivity {weight:2}]->(act1),
        (uspa2)-[:hasOperationsActivity {weight:2}]->(act2),
        (uspa1)-[:basedInHighGeoNamesLocation {weight:2}]->(uspaloc),
        (uspa2)-[:basedInHighGeoNamesLocation {weight:2}]->(uspaloc),
        (act1)-[:whereHighGeoNamesLocation {weight:2}]->(uspaloc),
        (act2)-[:whereHighGeoNamesLocation {weight:2}]->(uspaloc)
        """
    
    # node_data2 = [
        #     {"doc_id":101, "identifier":"usny1","node_type":"Organization"}, # US-NY
        #     {"doc_id":101, "identifier":"actny1","node_type":"OperationsActivity","datestamp":datestamp},
        #     {"doc_id":102, "identifier":"usnyloc","node_type":"GeoNamesLocation","datestamp":datestamp},
        # ]
    query2 = """CREATE
        (usny1:Resource:Organization {uri: 'https://1145.am/db/101/usny1', name: ['Name USNY1'], industry: ['baz'],   internalDocId: 101})-[:documentSource ]->(docsource_usny1:Resource:Article {uri: 'https://1145.am/db/article_usny1',
                        headline: 'Headline usny1', internalDocId: 101, sourceOrganization:'prweb', datePublished: datetime('2025-08-16T00:49:22.487877+00:00') }), (docsource_usny1)-[:url]->(ext_usny1:Resource { uri: 'https://example.org/external/art_usny1' }), 
                        (actny1:Resource:OperationsActivity {uri: 'https://1145.am/db/101/actny1', name: ['Name ACTNY1'],  status: ['some status'],   internalDocId: 101})-[:documentSource { documentExtract: 'Doc Extract ' }]->(docsource_usny1), 
                        
        (usnyloc:Resource:GeoNamesLocation {uri: 'https://1145.am/db/102/usnyloc', name: ['Name USNYLOC'],    countryCode: 'US',   admin1Code: 'NY',  internalDocId: 102})-[:documentSource ]->(docsource_usnyloc:Resource:Article {uri: 'https://1145.am/db/article_usnyloc',
                        headline: 'Headline usnyloc', internalDocId: 102, sourceOrganization:'prweb', datePublished: datetime('2025-08-15T23:59:59.999999+00:00') }), (docsource_usnyloc)-[:url]->(ext_usnyloc:Resource { uri: 'https://example.org/external/art_usnyloc' }),

        (usny1)-[:hasMarketingActivity {weight:2}]->(actny1),
        (usny1)-[:basedInHighGeoNamesLocation {weight:2}]->(usnyloc),
        (actny1)-[:whereHighGeoNamesLocation {weight:2}]->(usnyloc)

        """
    
    def normalize_for_test(self, acts):
        """
        Normalize neomodel objects inside acts so dict comparison works.
        """
        norm = copy.deepcopy(acts)
        for d in norm:
            if "activity_locations" in d:
                d["activity_locations"] = len(d["activity_locations"])
        return norm

    def test_updates_active_cache_version_and_clears_previous_version_keys(self):
        clean_db()
        nuke_cache()
        _,max_date = min_and_max_date({"max_date":date(2025,8,16)})
        db.cypher_query(self.query1)
        RDFPostProcessor().run_all_in_order()
        refresh_geo_data(fill_blanks=False,max_date=max_date)
        v1 = get_active_version()
        v2 = get_inactive_version()
        self.assertGreater( count_keys(f"*{v1}*orgs*"),0 ) # At least one active orgs key
        self.assertEqual( count_keys(f"*{v2}*orgs*"),0 )

        refresh_geo_data(fill_blanks=False,max_date=max_date)
        # now the versions should be switched around
        self.assertEqual( get_inactive_version(), v1)
        self.assertEqual( get_active_version(), v2 )
        self.assertEqual( count_keys(f"*{v1}*orgs*"),0 )
        self.assertGreater( count_keys(f"*{v2}*orgs*"),0 ) # At least one active orgs key

    def test_updates_next_cache_version(self):
        clean_db()
        nuke_cache()
        min_date,max_date = min_and_max_date({"max_date":date(2025,8,16)})
        
        db.cypher_query(self.query1)
        RDFPostProcessor().run_all_in_order()
        refresh_geo_data(fill_blanks=False,max_date=max_date)

        acts_pa1 = get_activities_by_country_and_date_range("US-PA",min_date,max_date)
        self.assertEqual(len(acts_pa1), 2) # uspa1 and uspa2
        with self.assertRaises(ValueError):
            _ = get_activities_by_country_and_date_range("US-NY",min_date,max_date)

        db.cypher_query(self.query2)
        RDFPostProcessor().run_all_in_order()
        with self.assertRaises(ValueError):
            get_activities_by_country_and_date_range("US-NY",min_date,max_date) # No results until refresh_geo_data
       
        refresh_geo_data(fill_blanks=False,max_date=max_date)

        acts_pa2 = get_activities_by_country_and_date_range("US-PA",min_date,max_date)
        self.assertEqual(
            self.normalize_for_test(acts_pa2), 
            self.normalize_for_test(acts_pa1)) # These have not changed
        
        acts_ny2 = get_activities_by_country_and_date_range("US-NY",min_date,max_date)
        self.assertEqual( len(acts_ny2), 1)

class TestDisentanglingMergedCells(TestCase):

    def test_unmerges_self_and_subsequent_nodes(self):
        '''
        wrong_loc linked to Node A
        ops x linked to Node A
        ops y linked to Node B
        ops z linked to Node C
        Node A is merged into Node B
        Node B is merged into Node C
        Node C is merged into Node D

        If we are deleting Node B then
        Need to know weights of all relationships with node B (except sameAsHigh)
        And remove that count of weights from node B, and also from C and D
        If weight drops to zero then delete
        weight should never be negative
        '''
        clean_db()
        node_data = [
            {"doc_id":10000,"identifier":"orga","node_type":"Organization"},
            {"doc_id":9999, "identifier":"orgb","node_type":"Organization"},
            {"doc_id":9998, "identifier":"orgc","node_type":"Organization"},
            {"doc_id":9997, "identifier":"orgd","node_type":"Organization"},
            {"doc_id":10000,"identifier":"acta","node_type":"OperationsActivity"},
            {"doc_id":9999, "identifier":"actb","node_type":"OperationsActivity"},            
            {"doc_id":9998, "identifier":"actc","node_type":"OperationsActivity"},
            {"doc_id":9997, "identifier":"actd","node_type":"OperationsActivity"},
            {"doc_id":33,   "identifier":"loc1","node_type":"GeoNamesLocation"},
            {"doc_id":340,  "identifier":"loc2","node_type":"GeoNamesLocation"},
        ]

        nodes = [make_node(**x) for x in node_data]
        node_list = ", ".join(nodes)

        query = f"""CREATE {node_list},
            (orga)-[:sameAsHigh]->(orgb),
            (orgb)<-[:sameAsHigh]-(orgc),
            (orgc)-[:sameAsHigh]->(orga),
            (orgc)-[:sameAsHigh]->(orgd),

            (orga)-[:hasOperationsActivity]->(acta),
            (orgb)-[:hasOperationsActivity]->(actb),
            (orgc)-[:hasOperationsActivity]->(actc),
            (orgd)-[:hasOperationsActivity]->(actd),

            (orga)-[:basedInHighGeoNamesLocation]->(loc1),
            (orgb)-[:basedInHighGeoNamesLocation]->(loc2),
            (orgc)-[:basedInHighGeoNamesLocation]->(loc1),
            (orgd)-[:basedInHighGeoNamesLocation]->(loc2)
        """

        db.cypher_query(query)
        RDFPostProcessor().run_all_in_order()

        target_uri = "https://1145.am/db/9997/orgd"
        target_node = Resource.get_by_uri(target_uri)

        uri_to_delete = "https://1145.am/db/9999/orgb"
        node_to_delete = Resource.get_by_uri(uri_to_delete)

        ''' Expected before
        orgd connects to all 4 acts
        orgd connects to both locs with weight 2 each        
        '''
        assert len(target_node.operations) == 4
        weights_query = f"MATCH (r: Resource {{uri:'{target_uri}'}})-[rel:basedInHighGeoNamesLocation]-(x) return x.uri, rel.weight"
        vals,_ = db.cypher_query(weights_query)
        assert len(vals) == 2, f"Got {vals} (expected 2 entries)"
        assert ['https://1145.am/db/33/loc1', 2] in vals
        assert ['https://1145.am/db/340/loc2', 2] in vals

        ''' Expect afterwards:
        orgd connects to acta,actc,actd
        orgd connects to loc1 with weight 2
        orgd connects to loc2 with weight 1
        '''
        node_to_delete.delete_node_and_related()

        assert len(target_node.operations) == 3
        vals,_ = db.cypher_query(weights_query)
        assert len(vals) == 2
        assert ['https://1145.am/db/33/loc1', 2] in vals
        assert ['https://1145.am/db/340/loc2', 1] in vals

    def test_finds_source_articles_for_org_industry(self):
        clean_db()
        node_data = [
            {"doc_id":10000,"identifier":"orga","node_type":"Organization"},
            {"doc_id":9999, "identifier":"orgb","node_type":"Organization"},
            {"doc_id":9998, "identifier":"orgc","node_type":"Organization"},
            {"doc_id":9997, "identifier":"orgd","node_type":"Organization"},
            {"doc_id":9996, "identifier":"orge","node_type":"Organization"},
            {"doc_id":33,   "identifier":"ind1","node_type":"IndustryCluster"},
            {"doc_id":34,   "identifier":"ind2","node_type":"IndustryCluster"},
        ]
        nodes = [make_node(**x) for x in node_data]
        node_list = ", ".join(nodes)
        query = f"""CREATE {node_list},
            (orga)-[:sameAsHigh]->(orgb),
            (orgb)<-[:sameAsHigh]-(orgc),
            (orgc)-[:sameAsHigh]->(orga),
            (orgc)-[:sameAsHigh]->(orgd),
            (orgb)-[:sameAsHigh]->(orge),

            (orga)-[:industryClusterPrimary]->(ind1),
            (orgb)-[:industryClusterPrimary]->(ind1),
            (orgc)-[:industryClusterPrimary]->(ind2),
            (orgd)-[:industryClusterPrimary]->(ind2),
            (orge)-[:industryClusterPrimary]->(ind2)
        """
        db.cypher_query(query)
        RDFPostProcessor().run_all_in_order()
        orga = Resource.get_by_uri('https://1145.am/db/10000/orga')
        orgb = Resource.get_by_uri('https://1145.am/db/9999/orgb')
        orgc = Resource.get_by_uri('https://1145.am/db/9998/orgc')
        orgd = Resource.get_by_uri('https://1145.am/db/9997/orgd')
        orge = Resource.get_by_uri('https://1145.am/db/9996/orge')
        ind1 = Resource.get_by_uri('https://1145.am/db/33/ind1')
        ind2 = Resource.get_by_uri('https://1145.am/db/34/ind2')
        ind1_orgs = get_source_orgs_for_ind_cluster_or_geo_code(orge,ind1)
        self.assertEqual(ind1_orgs, { (orga,1), (orgb,1 )})
        ind1_sources = get_source_orgs_articles_for(orge,ind1)
        res = set([(o.uri,weight,a.uri) for o,weight,a in ind1_sources])
        self.assertEqual(res, {
            ('https://1145.am/db/10000/orga', 1, 'https://1145.am/db/article_orga'),
            ('https://1145.am/db/9999/orgb',  1, 'https://1145.am/db/article_orgb')
        })
        ind2_orgs = get_source_orgs_for_ind_cluster_or_geo_code(orge, ind2)
        self.assertEqual(ind2_orgs, { (orge,3),(orgd,1),(orgc,1)}) 
        ind2_sources = get_source_orgs_articles_for(orge, ind2)
        self.assertEqual(set([(o.uri, weight,a.uri) for o,weight,a in ind2_sources]) , {
            ('https://1145.am/db/9996/orge', 3, 'https://1145.am/db/article_orge'), 
            ('https://1145.am/db/9998/orgc', 1, 'https://1145.am/db/article_orgc'), 
            ('https://1145.am/db/9997/orgd', 1, 'https://1145.am/db/article_orgd')
        })

    def test_finds_source_articles_for_org_location(self):
        clean_db()
        node_data = [
            {"doc_id":10000,"identifier":"orga","node_type":"Organization"},
            {"doc_id":9999, "identifier":"orgb","node_type":"Organization"},
            {"doc_id":9998, "identifier":"orgc","node_type":"Organization"},
            {"doc_id":9997, "identifier":"orgd","node_type":"Organization"},
            {"doc_id":33,   "identifier":"loc1","node_type":"GeoNamesLocation"}, # US-PA
            {"doc_id":340,  "identifier":"loc2","node_type":"GeoNamesLocation"}, # US-NY
        ]
        nodes = [make_node(**x) for x in node_data]
        node_list = ", ".join(nodes)
        query = f"""CREATE {node_list},
            (orga)-[:sameAsHigh]->(orgb),
            (orgb)<-[:sameAsHigh]-(orgc),
            (orgc)-[:sameAsHigh]->(orga),
            (orgc)-[:sameAsHigh]->(orgd),

            (orga)-[:basedInHighGeoNamesLocation]->(loc1),
            (orgc)-[:basedInHighGeoNamesLocation]->(loc2),
            (orgd)-[:basedInHighGeoNamesLocation]->(loc2)
        """
        db.cypher_query(query)
        RDFPostProcessor().run_all_in_order()
        orga = Resource.get_by_uri('https://1145.am/db/10000/orga')
        orgc = Resource.get_by_uri('https://1145.am/db/9998/orgc')
        orgd = Resource.get_by_uri('https://1145.am/db/9997/orgd')

        uspa_orgs = get_source_orgs_for_ind_cluster_or_geo_code(orgd, 'US-PA')
        assert uspa_orgs == { (orga,1) }, f"Got {uspa_orgs}"
        uspa_sources = get_source_orgs_articles_for(orgd, 'US-PA')
        assert set([(o.uri,weight,a.uri) for o,weight,a in uspa_sources]) == {
            ('https://1145.am/db/10000/orga', 1, 'https://1145.am/db/article_orga')
        }

        usny_orgs = get_source_orgs_for_ind_cluster_or_geo_code(orgd, 'US-NY')
        assert usny_orgs == { (orgd,2),(orgc,1)} 
        usny_sources = get_source_orgs_articles_for(orgd, 'US-NY')
        assert set([(o.uri, weight,a.uri) for o,weight,a in usny_sources]) == {
            ('https://1145.am/db/9998/orgc', 1, 'https://1145.am/db/article_orgc'), 
            ('https://1145.am/db/9997/orgd', 2, 'https://1145.am/db/article_orgd')
        }

        us_orgs = get_source_orgs_for_ind_cluster_or_geo_code(orgd, 'US')
        assert us_orgs == { (orga, 1), (orgc,1), (orgd, 3) }
        us_sources = get_source_orgs_articles_for(orgd, 'US')
        assert set([(o.uri, weight,a.uri) for o,weight,a in us_sources]) == {
            ('https://1145.am/db/9998/orgc',  1, 'https://1145.am/db/article_orgc'), 
            ('https://1145.am/db/10000/orga', 1, 'https://1145.am/db/article_orga'), 
            ('https://1145.am/db/9997/orgd',  3, 'https://1145.am/db/article_orgd')
        }


class TestTypesenseDocs(TestCase):

    fake_geonames = [
        GeoNamesLocation(geoNamesId=12345, countryCode="XY", admin1Code=None),
        GeoNamesLocation(geoNamesId=12346, countryCode="US", admin1Code="00"),
        GeoNamesLocation(geoNamesId=12347, countryCode="US", admin1Code="AB"),
        GeoNamesLocation(geoNamesId=12348, countryCode="US", admin1Code="CA"),
        GeoNamesLocation(geoNamesId=12349, countryCode="US", admin1Code="CA"),
        GeoNamesLocation(geoNamesId=12350, countryCode="LM", admin1Code="LL"),
    ]

    resource_fields = {
        "uri": "https://example.org/foo/bar",
        "internalId": 123,
        "internalDocId": 456,
        "internalMergedSameAsHighToUri": None,
    }

    embedding1 = [0.1] * 768
    embedding2 = [0.2] * 768
 
    @patch.object(Organization, "basedInHighGeoNamesLocation")
    def test_converts_org_object_to_typesense(self, mock_geo):
        mock_geo.__iter__.return_value = iter(self.fake_geonames)
        org = Organization( ** (self.resource_fields | 
                                {"industry":["bar","baz"],
                                 "name":["foo","qux","qua"], 
                                 "basedInHighGeoNamesLocation": mock_geo,
                                 "top_industry_names_embedding_json": [self.embedding1, self.embedding2],
                                 })
        )
        as_ts_doc = org.to_typesense_doc()
        self.assertEqual( len(as_ts_doc), 4 )
        self.assertEqual( as_ts_doc[0]["embedding"], self.embedding1)
        self.assertEqual( as_ts_doc[1]["embedding"], self.embedding2)
        self.assertEqual( as_ts_doc[2]["embedding"], None) # Name info
        self.assertEqual( as_ts_doc[3]["embedding"], None) # Name info
        self.assertEqual( set(as_ts_doc[0]["region_list"]), {'LM', 'US', 'US-AB', 'US-CA', 'XY'} )
        self.assertEqual( set(as_ts_doc[1]["region_list"]), set(as_ts_doc[0]["region_list"]))
        self.assertEqual( set(as_ts_doc[2]["region_list"]), set(as_ts_doc[0]["region_list"]))
        self.assertEqual( set(as_ts_doc[3]["region_list"]), set(as_ts_doc[0]["region_list"]))
        self.assertEqual( as_ts_doc[0]["name"], "foo")
        self.assertEqual( as_ts_doc[1]["name"], "foo")
        self.assertEqual( as_ts_doc[2]["name"], "qux")
        self.assertEqual( as_ts_doc[3]["name"], "qua")


    @patch.object(IndustrySectorUpdate, "whereHighGeoNamesLocation")
    def test_converts_ind_sector_update_object_to_typesense(self, mock_geo):
        mock_geo.__iter__.return_value = iter(self.fake_geonames)

        mock_rel = MagicMock()
        mock_rel.all.return_value = []
        mock_rel._new_traversal = []

        ind = IndustrySectorUpdate( ** (self.resource_fields |
                                   {"whereHighGeoNamesLocation": mock_geo,
                                   "industry_embedding_json": [self.embedding1, self.embedding2],
                                   "mentionedIn": mock_rel,
                                   }))
        as_ts_doc = ind.to_typesense_doc()
        self.assertEqual( len(as_ts_doc), 2)
        self.assertEqual( set(as_ts_doc[0]["region_list"]), {'LM', 'US', 'US-AB', 'US-CA', 'XY'} )
        self.assertEqual( set(as_ts_doc[1]["region_list"]), set(as_ts_doc[0]["region_list"]) )
        self.assertEqual( as_ts_doc[0]["embedding"], self.embedding1)
        self.assertEqual( as_ts_doc[1]["embedding"], self.embedding2)
        self.assertEqual( as_ts_doc[0]["id"], '123_ind_upd_0')
    
    @patch.object(Organization, "basedInHighGeoNamesLocation")
    @patch.object(AboutUs, "aboutUs")
    def test_converts_about_us_object_to_typesense(self, mock_org_rel, mock_geo):
        mock_geo.__iter__.return_value = iter(self.fake_geonames)
        org_uri = "http://example.org/bar/baz"
        org = Organization( ** (self.resource_fields | 
                                {"uri": org_uri,
                                 "industry":["bar","baz"],
                                 "name":["foo","qux","qua"], 
                                 "basedInHighGeoNamesLocation": mock_geo,
                                 "internalId": 12345,
                                 "top_industry_names_embedding_json": [self.embedding1, self.embedding2],
                                 })
        )
        
        mock_org_rel.filter.return_value = [org]
        about = AboutUs( ** (self.resource_fields) |
                        {"name_embedding_json": [self.embedding1, self.embedding2],
                         "aboutUs": mock_org_rel})
        as_ts_doc = about.to_typesense_doc()
        self.assertEqual( len(as_ts_doc), 2)
        self.assertEqual( set(as_ts_doc[0]["region_list"]), {'LM', 'US', 'US-AB', 'US-CA', 'XY'})
        self.assertEqual( set(as_ts_doc[1]["region_list"]), set(as_ts_doc[0]["region_list"]) )
        self.assertEqual( as_ts_doc[0]["embedding"], self.embedding1)
        self.assertEqual( as_ts_doc[1]["embedding"], self.embedding2)
        self.assertEqual( as_ts_doc[0]["related_org_uris"], [org_uri])
        self.assertEqual( as_ts_doc[1]["related_org_uris"], [org_uri])
        self.assertEqual( as_ts_doc[0]["uri"], "https://example.org/foo/bar")
        self.assertEqual( as_ts_doc[1]["uri"], "https://example.org/foo/bar")

    def test_converts_ind_cluster_object_to_typesense(self):
        ind = IndustryCluster( ** (self.resource_fields |
                                   {"topicId": 99,
                                    "representative_doc_embedding_json": [self.embedding1, self.embedding2]}
                                 ))
        as_ts_doc = ind.to_typesense_doc()
        self.assertEqual( len(as_ts_doc), 2)
        self.assertEqual( as_ts_doc[0]["topic_id"], 99)
        self.assertEqual( as_ts_doc[1]["topic_id"], 99)
        self.assertEqual( as_ts_doc[0]["embedding"], self.embedding1)
        self.assertEqual( as_ts_doc[1]["embedding"], self.embedding2)
